Publications

regional journals & presentations

2023

south africa
Publication Outputs:

RePORT SA supported 27 peer-reviewed publications by RePORT investigators.

SATVI:
Mulenga H, Musvosvi M, Mendelsohn SC, Penn-Nicholson A, Kimbung Mbandi S, Fiore-Gartland A, Tameris M, Mabwe S, Africa H, Bilek N, Kafaar F, Khader SA, Carstens B, Hadley K, Hikuam C, Erasmus M, Jaxa L, Raphela R, Nombida O, Kaskar M, Nicol MP, Mbhele S, Van Heerden J, Innes C, Brumskine W, Hiemstra A, Malherbe ST, Hassan-Moosa R, Walzl G, Naidoo K, Churchyard G, Hatherill M, Scriba TJ; CORTIS Study Team. Longitudinal Dynamics of a Blood Transcriptomic Signature of Tuberculosis. Am J Respir Crit Care Med. 2021 Dec 15;204(12):1463-1472. doi: 10.1164/rccm.202103-0548OC.PMID: 34520313

SUN:
Beltran CGG, Heunis T, Gallant J, Venter R, du Plessis N, Loxton AG, Trost M, Winter J, Malherbe ST, Kana BD, Walzl G. Investigating Non-sterilizing Cure in TB Patients at the End of Successful Anti-TB Therapy. Front Cell Infect Microbiol. 2020 Aug 25;10:443. doi: 10.3389/fcimb.2020.00443. PMID: 32984071; PMCID: PMC7477326.

Malherbe ST, Chen RY, Dupont P, Kant I, Kriel M, Loxton AG, Smith B, Beltran CGG, van Zyl S, McAnda S, Abrahams C, Maasdorp E, Doruyter A, Via LE, Barry CE 3rd, Alland D, Richards SG, Ellman A, Peppard T, Belisle J, Tromp G, Ronacher K, Warwick JM, Winter J, Walzl G. Quantitative 18F-FDG PET-CT scan characteristics correlate with tuberculosis treatment response. EJNMMI Res. 2020 Feb 10;10(1):8. doi: 10.1186/s13550-020-0591-9. PMID: 32040770; PMCID: PMC7010890.

Chen RY, Via LE, Dodd LE, Walzl G, Malherbe ST, Loxton AG, Dawson R, Wilkinson RJ, Thienemann F, Tameris M, Hatherill M, Diacon AH, Liu X, Xing J, Jin X, Ma Z, Pan S, Zhang G, Gao Q, Jiang Q, Zhu H, Liang L, Duan H, Song T, Alland D, Tartakovsky M, Rosenthal A, Whalen C, Duvenhage M, Cai Y, Goldfeder LC, Arora K, Smith B, Winter J, Barry Iii CE; Predict TB Study Group. Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trial. Gates Open Res. 2017 Nov 6;1:9. doi: 10.12688/gatesopenres.12750.1. PMID: 29528048; PMCID: PMC5841574.

UP:
Lawal IO, Fourie BP, Mathebula M, Moagi I, Lengana T, Moeketsi N, Nchabeleng M, Hatherill M, Sathekge MM. <sup>18</sup>F-FDG PET/CT as a Noninvasive Biomarker for Assessing Adequacy of Treatment and Predicting Relapse in Patients Treated for Pulmonary Tuberculosis. J Nucl Med. 2020 Mar;61(3):412-417. doi: 10.2967/jnumed.119.233783. Epub 2019 Aug 26. PMID: 31451489.

Osei Sekyere J, Reta MA, Maningi NE, Fourie PB. Antibiotic resistance of Mycobacterium tuberculosis complex in Africa: A systematic review of current reports of molecular epidemiology, mechanisms and diagnostics. J Infect. 2019 Dec;79(6):550-571. doi: 10.1016/j.jinf.2019.10.006. Epub 2019 Oct 16. PMID: 31629017.

Lawal IO, Fourie BP, Mathebula M, Moagi I, Lengana T, Moeketsi N, Nchabeleng M, Hatherill M, Sathekge MM. 18F-FDG PET/CT as a Noninvasive Biomarker for Assessing Adequacy of Treatment and Predicting Relapse in Patients Treated for Pulmonary Tuberculosis. J Nucl Med. 2020 Mar;61(3):412-417. doi: 10.2967/jnumed.119.233783. Epub 2019 Aug 26. PMID: 31451489.

UCTLI
Tavaziva G, Harris M, Abidi SK, Geric C, Breuninger M, Dheda K, Esmail A, Muyoyeta M, Reither K, Majidulla A, Khan AJ, Campbell JR, David PM, Denkinger C, Miller C, Nathavitharana R, Pai M, Benedetti A, Ahmad Khan F. Chest X-ray Analysis With Deep Learning-Based Software as a Triage Test for Pulmonary Tuberculosis: An Individual Patient Data Meta-Analysis of Diagnostic Accuracy. Clin Infect Dis. 2022 Apr 28;74(8):1390-1400. doi: 10.1093/cid/ciab639. PMID: 34286831; PMCID: PMC9049274.

Theron G, Limberis J, Venter R, Smith L, Pietersen E, Esmail A, Calligaro G, Te Riele J, de Kock M, van Helden P, Gumbo T, Clark TG, Fennelly K, Warren R, Dheda K. Bacterial and host determinants of cough aerosol culture positivity in patients with drug-resistant versus drug-susceptible tuberculosis. Nat Med. 2020 Sep;26(9):1435-1443. doi: 10.1038/s41591-020-0940-2. Epub 2020 Jun 29. PMID: 32601338; PMCID: PMC8353872

Esmail A, Tomasicchio M, Meldau R, Makambwa E, Dheda K. Comparison of Xpert MTB/RIF (G4) and Xpert Ultra, including trace readouts, for the diagnosis of pulmonary tuberculosis in a TB and HIV endemic setting. Int J Infect Dis. 2020 Jun;95:246-252. doi: 10.1016/j.ijid.2020.03.025. Epub 2020 Apr 2. PMID: 32247825.

Esmail A, Randall P, Oelofse S, Tomasicchio M, Pooran A, Meldau R, Makambwa E, Mottay L, Jaumdally S, Calligaro G, Meier S, de Kock M, Gumbo T, Warren RM, Dheda K. Comparison of two diagnostic intervention packages for community-based active case finding for tuberculosis: an open-label randomized controlled trial. Nat Med. 2023 Apr;29(4):1009-1016. PMID: 36894651.

PHRU
Moyo M, Lebina L, Milovanovic M, MacPherson P, Michel A, Martinson N. Tuberculosis patients at the human-animal interface: Potential zooanthroponotic and zoonotic transmission. One Health. 2021 Aug 30;13:100319. doi: 10.1016/j.onehlt.2021.100319. PMID: 34504938; PMCID: PMC8417387

AHRI
Ndlovu LN, Peetluk L, Moodley S, Nhamoyebonde S, Ngoepe AT, Mazibuko M, Khan K, Karim F, Pym AS, Maruri F, Moosa MS, van der Heijden YF, Sterling TR, Leslie A. Increased Neutrophil Count and Decreased Neutrophil CD15 Expression Correlate With TB Disease Severity and Treatment Response Irrespective of HIV Co-infection. Front Immunol. 2020 Aug 28;11:1872. doi: 10.3389/fimmu.2020.01872. PMID: 32983107; PMCID: PMC7485225.

Walker NF, Karim F, Moosa M, Moodley S, Mazibuko M, Khan K, Sterling TR, van der Heijden YF, Grant AD, Elkington PT, Pym A, Leslie A. Elevated plasma matrix metalloproteinase-8 associates with sputum culture positivity in pulmonary tuberculosis. J Infect Dis. In press

Arriaga MB, Karim F, Queiroz ATL, Araújo-Pereira M, Barreto-Duarte B, Sales C, Moosa MYS, Mazibuko M, Milne GL, Maruri F, Serezani CH, Koethe JR, Figueiredo MC, Kritski AL, Cordeiro-Santos M, Rolla VC, Sterling TR, Leslie A, Andrade BB, for the RePORT-Brazil and -South Africa consortia. Effect of dysglycemia on urinary lipid mediator profiles in persons with pulmonary tuberculosis. Front Immunol. In press.

REACH
Cox H, Workman L, Bateman L, Franckling-Smith Z, Prins M, Luiz J, Van Heerden J, Edries LAT, Africa S, Allen V, Baard C, Zemanay W, Nicol MP, Zar HJ. Oral swabs tested with Xpert MTB/RIF Ultra for diagnosis of pulmonary tuberculosis in children: a diagnostic accuracy study. Clin Infect Dis. 2022 May 17:ciac332. doi: 10.1093/cid/ciac332. Epub ahead of print. PMID: 35579497.

Copelyn J, Eley B, Cox H, Workman L, Dheda K, Nicol MP, Zar HJ. Treatment Response in Pediatric Pulmonary Tuberculosis-A Prospective Longitudinal Study. J Pediatric Infect Dis Soc. 2022 Apr 24:piac029. doi: 10.1093/jpids/piac029. Epub ahead of print. PMID: 35462407.

Nel M, Franckling-Smith Z, Pillay T, Andronikou S, Zar HJ. Chest Imaging for Pulmonary TB – An Update. Pathogens. 2022;11:161. doi:10.3390/pathogens11020161.

Nicol MP, Schumacher SG, Workman L, Broger T, Baard C, Prins M, Bateman L, du Toit E, van Heerden J, Szekely R, Zar HJ, Denkinger CM. Accuracy of a Novel Urine Test, Fujifilm SILVAMP Tuberculosis Lipoarabinomannan, for the Diagnosis of Pulmonary Tuberculosis in Children. Clin Infect Dis. 2021 May 4;72(9):e280-e288. doi: 10.1093/cid/ciaa1052. PMID: 32761178; PMCID: PMC8096212.

Bobak CA, Kang L, Workman L, Bateman L, Khan MS, Prins M, May L, Franchina FA, Baard CB, Nicol M, Zar H, Hill JE. Breath can discriminate tuberculosis from other lower respiratory illness in children. Sci Rep. 2021;11:2704. doi:10.1038/s41598-021-80970-w.

DeAtley T, Workman L, Theron G,  Bélard S, Prins M, Bateman L, Grobusch MP, Dheda K, Nicol MP, Sorsdahl K, Kuo C, Stein DJ, Zar HJ. The child ecosystem and childhood pulmonary tuberculosis: A South African perspective. Pediatric Pulmonol. 2021 Feb;56:2212-2222. doi:10.1002/ppul.25369.

Marais BJ, Nicol M, Zar HJ. Key advances and remaining challenges in childhood and adolescent tuberculosis. Paediatr Respir Rev. 2020 Nov;36:25-26. doi: 10.1016/j.prrv.2020.07.008. Epub 2020 Aug 1. PMID: 32830068.

Nicol MP, Zar HJ. Advances in the diagnosis of pulmonary tuberculosis in children. Paediatr Respir Rev. 2020 Nov;36:52-56. doi:10.1016/j.prrv.2020.05.003. Epub 2020 May 25. PMID: 32624357; PMCID: PMC7686111.

Pillay T, Andornikou S, Zar HJ. Chest imaging in paediatric pulmonary TB. Paediatric Respir Rev. 2020;36:65-72. doi:10.1016/j.prrv.2020.10.002.

Zar HJ, Workman LJ, Prins M, Bateman LJ, Mbhele SP, Whitman CB, Denkinger CM, Nicol MP. Tuberculosis Diagnosis in Children Using Xpert Ultra on Different Respiratory Specimens. Am J Respir Crit Care Med. 2019 Dec 15;200(12):1531-1538. doi: 10.1164/rccm.201904-0772OC. PMID: 31381861; PMCID: PMC6909828.

Nicol MP, Wood RC, Workman L, Prins M, Whitman C, Ghebrekristos Y, Mbhele S, Olson A, Jones-Engel LE, Zar HJ, Cangelosi GA. Microbiological diagnosis of pulmonary tuberculosis in children by oral swab polymerase chain reaction. Sci Rep. 2019 Jul 25;9(1):10789. doi: 10.1038/s41598-019-47302-5. PMID: 31346252;PMCID: PMC6658562.

Nicol MP, Workman L, Prins M, Bateman L, Ghebrekristos Y, Mbhele S, Denkinger CM, Zar HJ. Accuracy of Xpert Mtb/Rif Ultra for the Diagnosis of Pulmonary Tuberculosis in Children. Pediatr Infect Dis J. 2018
Oct;37(10):e261-e263. doi: 10.1097/INF.0000000000001960. PMID: 29474257.

RePORT International:
van der Heijden YF, Abdullah F, Andrade BB, Andrews JR, Christopher DJ, Croda J, Ewing H, Haas DW, Hatherill M, Horsburgh CR Jr, Mave V, Nakaya HI, Rolla V, Srinivasan S, Sugiyono RI, Ugarte-Gil C, Hamilton C. Building capacity for advances in tuberculosis research; proceedings of the third RePORT international meeting. Tuberculosis (Edinb). 2018 Dec;113:153-162. doi: 10.1016/j.tube.2018.09.009. Epub 2018 Oct 1. PMID: 30514497; PMCID: PMC6349374.

India

Bhagwan Mahavir Medical Research Centre – University of Texas Health Science Center at Tyler (CRU 107)

  1. Metabolites enhance innate resistance to human Mycobacterium tuberculosis infection
    Tripathi D, Devalraju KP, Neela VSK, Paidipally P, Radhakrishnan RK, Mukherjee T, Dozmorov I, Bogam AK, Mallidi V, Ansari MS, Valluri VL, Vankayalapati R. JCI Insight. 2022 Nov 22;7(22):e152357. doi: 10.1172/jci.insight.152357. PMID: 36509283; PMCID: PMC9746823.

Byramjee Jeejeebhoy Government Medical College – National Institute for Research in Tuberculosis – Johns Hopkins University (CRUs 106 & 105)

  1. Characterising cause of death among people treated for drug- susceptible TB in India
    Cox SR, Padmapriyadarsini C, Mave V, Seth B, Thiruvengadam K, Gaikwad S, Sahasrabudhe TR, Sane M, Tornheim JA, Shrinivasa BM, Lokhande R, Barthwal MS, Shivakumar VBY, Krishnan S, Santhappan R, Kinikar A, Kakrani AL, Paradkar M, Bollinger RC, Sekar K, Gupte AN, Hanna LE, Gupta A, Golub JE, on behalf of the CTRIUMPH and TBDM Study Teams. Int J Tuberc Lung Dis. 2023;27(1):78-80. http://dx.doi.org/10.5588/ijtld.22.0454
  2. Predictive performance of interferon-gamma release assays and the tuberculin skin test for incident tuberculosis: an individual participant data meta-analysis
    Hamada Y, Gupta RK, Quartagno M, Izzard A, Acuna-Villaorduna C, Altet N, Diel R, Dominguez J, Floyd S, Gupta A, Huerga H, Jones-López EC, Kinikar A, Lange C, van Leth F, Liu Q, Lu W, Lu P, Rueda IL, Martinez L, Mbandi SK, Muñoz L, Padilla ES, Paradkar M, Scriba T, Sester M, Shanaube K, Sharma SK, Sloot R, Sotgiu G, Thiruvengadam K, Vashishtha R, Abubakar I, Rangaka MX.  EClinicalMedicine. 2023 Jan 5;56:101815. doi: 10.1016/j.eclinm.2022.101815. PMID: 36636295; PMCID: PMC9829704.
  3. QuantiFERON supernatant-based host biomarkers predicting progression to active tuberculosis disease among household contacts of tuberculosis patients
    Daniel EA, Thiruvengadam K, Rajamanickam A, Chandrasekaran P, Pattabiraman S, Bhanu B, Sivaprakasam A, Paradkar M, Kulkarni V, Karyakarte R, Shivakumar SVBY, Mave V, Gupta A, Babu S, Hanna LE. Clin Infect Dis. 2022 Dec 30:ciac979. doi: 10.1093/cid/ciac979. Epub ahead of print. PMID: 36582115.
  4. Sex differences in tuberculosis clinical presentation, drug exposure, and treatment outcomes in India
    Deshmukh S, Sane M, Gaikwad S, Sahasrabudhe T, Barthwal M, Lokhande R, Raskar S, Kagal A, Dharmshale S, Pradhan N, Gupte A, Alfarisi O, Gupta A, Dooley KE, Gupte N, Golub JE, Mave V. Chest. 2022 Sep 26:S0012-3692(22)03893-4. doi: 10.1016/j.chest.2022.09.024. Epub ahead of print. PMID: 36174745.
  5. Whole genome sequencing assessing impact of diabetes mellitus on tuberculosis mutations and type of recurrence in India   
    Mave V, Chen L., Ranganathan U D, Kadam D, Vishwanathan V, Lokhande R, S, S. K., Kagal A, Neeta, Shivakumar SVBY, Paradkar MS, Deshmukh S, Tornheim JA, Kornfeld H, Farhat M, Gupta A, Padmapriyadarsini C, Gupte N, Golub JE, Mathema B, & Kreiswirth BN. Clin Infect Dis. 2022 Sep 14;75(5):768-776. doi: 10.1093/cid/ciab1067. PMID: 34984435; PMCID: PMC9477453.
  6. Baseline IL-6 is a biomarker for unfavourable tuberculosis treatment outcomes: a multisite discovery and validation study
    Gupte AN, Kumar P, Araújo-Pereira M, Kulkarni V, Paradkar M, Pradhan N, Menon P, Padmapriyadarsini C, Hanna LE, Yogendra Shivakumar SVB, Rockwood N, Du Bruyn E, Karyakarte R, Gaikwad S, Bollinger R, Golub J, Gupte N, Viswanathan V, Wilkinson RJ, Mave V, Babu S, Kornfeld H, Andrade BB, Gupta A. Eur Respir J. 2022 Apr 21;59(4):2100905. doi: 10.1183/13993003.00905-2021. PMID: 34711538; PMCID: PMC7612881.
  7. Concomitant pulmonary disease is common among patients with extrapulmonary TB
    Shivakumar SVBY, Padmapriyadarsini C, Chavan A, Paradkar M, Shrinivasa BM, Gupte A, Dhanasekaran K, Thomas B, Suryavanshi N, Dolla CK, Selvaraju S, Kinikar A, Gaikwad S, Kohli R, Sivaramakrishnan GN, Pradhan N, Hanna LE, Kulkarni V, DeLuca A, Cox SR, Murali L, Thiruvengadam K, Raskar S, Ramachandran G, Golub JE, Gupte N, Mave V, Swaminathan S, Gupta A, Bollinger RC. Int J Tuberc Lung Dis. 2022 Apr 1;26(4):341-347. doi: 10.5588/ijtld.21.0501. PMID: 35351239; PMCID: PMC8982647.
  8. Host lipidome and tuberculosis treatment failure
    Shivakoti R, Newman JW, Hanna LE, Queiroz ATL, Borkowski K, Gupte AN, Paradkar M, Satyamurthi P, Kulkarni V, Selva M, Pradhan N, Shivakumar SVBY, Natarajan S, Karunaianantham R, Gupte N, Thiruvengadam K, Fiehn O, Bharadwaj R, Kagal A, Gaikwad S, Sangle S, Golub JE, Andrade BB, Mave V, Gupta A, Padmapriyadarsini C. Eur Respir J. 2022 Jan 6;59(1):2004532. doi: 10.1183/13993003.04532-2020. PMID: 34375300; PMCID: PMC9625841.
  9. The kynurenine/tryptophan ratio is a sensitive biomarker for the diagnosis of pediatric tuberculosis among Indian children
    Tornheim JA, Paradkar M, Zhao H, Kulkarni V, Pradhan N, Kinikar A, Kagal A, Gupte N, Mave V, Gupta A, Karakousis PC. Front Immunol. 2022 Jan 12;12:774043. doi: 10.3389/fimmu.2021.774043. PMID: 35095848; PMCID: PMC8790563.

Christian Medical College, Vellore – University of Cambridge – University of Washington (CRU 101)

  1. Accuracy of Xpert MTB/RIF Ultra for the diagnosis of tuberculosis in adult patients: a retrospective cohort study
    Kaswala C, Schmiedel Y, Kundu D, George MM, Dayanand D, Devasagayam E, S AM, Kumar SS, Michael JS, Ninan MM, Chacko G, Zachariah A, Sathyendra S, Hansdak SG, Iyadurai R, Christopher DJ, Gupta R, Karthik R, Abraham OC, Varghese GM. Int J Infect Dis. 2022 Sep;122:566-568. doi: 10.1016/j.ijid.2022.07.016. Epub 2022 Jul 8. PMID: 35811084.
  2. Semantic segmentation of bone structures in chest X-rays including unhealthy radiographs: A robust and accurate approach
    Singh A, Lall B, Panigrahi BK, Agrawal A, Agrawal A, Thangakunam B, Christopher DJ. Int J Med Inform. 2022 Sep;165:104831. doi: 10.1016/j.ijmedinf.2022.104831. Epub 2022 Jul 18. PMID: 35870303.
  3. Impact of undernutrition on tuberculosis treatment outcomes in India: A multicenter prospective cohort analysis
    Sinha P, Ponnuraja C, Gupte N, Babu SP, Cox SR, Sarkar S, Mave V, Paradkar M, Cintron C, Govindarajan S, Kinikar A, Priya N, Gaikwad S, Thangakunam B, Devarajan A, Dhanasekaran M, Tornheim JA, Gupta A, Salgame P, Christopher DJ, Kornfeld H, Viswanathan V, Ellner JJ, Horsburgh CR, Gupte AN, Padmapriyadarsini C, Hochberg NS. Clin Infect Dis. 2022 Nov 25:ciac915. doi: 10.1093/cid/ciac915. Epub ahead of print. PMID: 36424864.

Jawaharlal Institute of Postgraduate Medical Education & Research – Boston Medical Center/Boston University
Rutgers (CRU 102)

  1. Psychometric properties of the Household Food Insecurity Assess Scale among households with tuberculosis patients in South India
    (Accepted in Progress in Nutrition) Yuvaraj Krishnamoorthy, Sathish Rajaa, Komala Ezhumalai, Selby Knudsen C, Robert Horsburgh Jr., Natasha S. Hochberg, Padmini Salgame, Jerrold Ellner, Senbagavalli PB, Sonali Sarkar
  2. Comparison of IGRA and TST in the diagnosis of latent tuberculosis among women of reproductive age in South India
    Senbagavalli Prakash Babu, Komala Ezhumalai, Kalaivani Raghupathy, Madhusudanan Sundaresan, Komal Jain, Prakash Babu Narasimhan, Selby Knudsen, Robert Horsburgh, Natasha Hochberg, Padmini Salgame, Jerrold Ellner, Sonali Sarkar. Indian Journal of Tuberculosis https://doi.org/10.1016/j.ijtb.2022.03.011.
  3. Effect of treatment adherence on the association between sex and unfavourable treatment outcomes among tuberculosis patients in Puducherry, India: a mediation analysis
    Barathi A, Krishnamoorthy Y, Sinha P, Horsburgh C, Hochberg N, Johnson E, Salgame P, Govindarajan S, Senbagavalli PB, Lakshinarayanan S, Roy G, Ellner J, Sarkar S. J Public Health (Oxf). 2022 Jun 11:fdac062. doi: 10.1093/pubmed/fdac062. Epub ahead of print. PMID: 35692180.
  4. Development of prognostic scoring system for predicting 1-year mortality among pulmonary tuberculosis patients in South India
    Krishnamoorthy Y, Ezhumalai K, Murali S, Rajaa S, Majella MG, Sarkar S, Lakshminarayanan S, Joseph NM, Soundappan G, Prakash Babu S, Horsburgh C, Hochberg N, Johnson WE, Knudsen S, Pentakota SR, Salgame P, Roy G, Ellner J. J Public Health (Oxf). 2022 Aug 27:fdac087. doi: 10.1093/pubmed/fdac087. Epub ahead of print. PMID: 36038507.
  5. Malnutrition leads to increased inflammation and expression of tuberculosis risk signatures in recently exposed household contacts of pulmonary tuberculosis VanValkenburg A, Kaipilyawar V, Sarkar S, Lakshminarayanan S, Cintron C, Prakash Babu S, Knudsen S, Joseph NM, Horsburgh CR, Sinha P, Ellner JJ, Narasimhan PB, Johnson WE, Hochberg NS, Salgame P. Front Immunol. 2022 Sep 28;13:1011166. doi: 10.3389/fimmu.2022.1011166. Erratum in: Front Immunol. 2022 Oct 20;13:1064883. PMID: 36248906; PMCID: PMC9554585.
  6. Predictors of weight loss during the intensive phase of tuberculosis treatment in patients with drug-susceptible pulmonary tuberculosis in South India
    Kalva J, Babu SP, Narasimhan PB, Raghupathy K, Ezhumalai K, Knudsen S, Horsburgh CR, Hochberg N, Salgame P, Roy G, Ellner J, Sarkar S. J Public Health (Oxf). 2022 Nov 30:fdac141. doi: 10.1093/pubmed/fdac141. Epub ahead of print. PMID: 36451280.
  7. Impact of Undernutrition on Tuberculosis Treatment Outcomes in India: A Multicenter Prospective Cohort Analysis.
    Sinha P, Ponnuraja C, Gupte N, Babu SP, Cox SR, Sarkar S, Mave V, Paradkar M, Cintron C, Govindarajan S, Kinikar A, Priya N, Gaikwad S, Thangakunam B, Devarajan A, Dhanasekaran M, Tornheim JA, Gupta A, Salgame P, Christopher DJ, Kornfeld H, Viswanathan V, Ellner JJ, Horsburgh CR, Gupte AN, Padmapriyadarsini C, Hochberg NS. Clin Infect Dis. 2022 Nov 25:ciac915. doi: 10.1093/cid/ciac915. Epub ahead of print. PMID: 36424864.
  8. Development and validation of a parsimonious TB gene signature using the digital NanoString nCounter platform
    Kaipilyawar V, Zhao Y, Wang X, Joseph NM, Knudsen S, Babu SP, Muthaiah M, Hochberg NS, Sarkar S, Horsburgh CR, Jr., Ellner JJ, Johnson WE, Salgame P. Clin Infect Dis. 2022. Epub 2022/01/12. doi:10.1093/cid/ciac010. PubMed PMID: 35015839.

MVDRC, NIRT – ICER, UMass

  1. Chitinase and indoleamine 2, 3-dioxygenase are prognostic biomarkers for unfavourable treatment outcomes in pulmonary tuberculosis
    Kumar NP, Nancy A, Viswanthan V, Shanmugam S, Thiruvengadam K, Ahamed SF, Hissar S, Kornfeld H, Babu S. Frontiers in Immunology. In press
  2. Longitudinal Trends in Glycated Hemoglobin During and after Tuberculosis Treatment
    Kornfeld H, Procter-Gray E, Kumpatla S, Kane K, Li W, Magee MJ, Babu S, Viswanathan V. Diabetes Res Clin Pract. 2023 Jan 7:110242. doi: 10.1016/j.diabres.2023.110242. Online ahead of print.. PMID: 36627027
  3. Heightened microbial translocation is a prognostic biomarker of recurrent tuberculosis
    Kumar NP, Moideen K, Viswanathan V, Sivakumar S, Ahamed SF, Ponnuraja C, Hissar S, Kornfeld H, Babu S. Clin Infect Dis. 2022 Nov 14;75(10):1820-1826. doi: 10.1093/cid/ciac236. PMID: 35352112; PMCID: PMC9662171.

P.D. Hinduja National Hospital & Medical Research Center – Johns Hopkins University (CRU 108)

  1. Pharmacokinetic analysis of linezolid for multidrug resistant tuberculosis at a tertiary care centre in Mumbai, India
    Resendiz-Galvan JE, Arora PR, Abdelwahab MT, Udwadia ZF, Rodrigues C, Gupta A, Denti P, Ashavaid TF, Tornheim JA. Front Pharmacol. 2023 Jan 4;13:1081123. doi: 10.3389/fphar.2022.1081123. PMID: 36686664; PMCID: PMC9846493.
  2. Cycloserine did not increase depression incidence or severity at standard dosing for multidrug-resistant tuberculosis
    Tornheim JA, Udwadia ZF, Arora PR, Gajjar I, Gupte N, Sharma S, Karane M, Sawant N, Kharat N, Blum AJ, Shivakumar SV. Eur Respir J. 2022 Mar 24;59(3):2102511. doi: 10.1183/13993003.02511-2021. PMID: 34949698; PMCID: PMC8943271.

2022

south africa
  1. Correlation Between CT Features of Active Tuberculosis and Residual Metabolic Activity on End-of-Treatment FDG PET/CT in Patients Treated for Pulmonary Tuberculosis.
    Lawal IO, Mokoala KMG, Mathebula M, Moagi I, Popoola GO, Moeketsi N, Nchabeleng M, Hikuam C, Ellner JJ, Hatherill M, Fourie BP, Sathekge MM.
    Front Med (Lausanne). 2022 Feb 22;9:791653. doi: 10.3389/fmed.2022.791653. eCollection 2022.
    PMID: 35295606
India

Hinduja

  1. Targeted next-generation sequencing directly from sputum for comprehensive genetic information on drug-resistant Mycobacterium tuberculosis.
    Kambli P, Ajbani K, Kazi M, Sadani M, Naik S, Shetty A, Tornheim JA, Singh H, Rodrigues C. Tuberculosis (Edinb). 2021 Mar;127:102051. doi: 10.1016/j.tube.2021.102051. Epub 2021 Jan 8. PMID: 33450448.

MVDRC

  1. Acute Phase Proteins Are Baseline Predictors of Tuberculosis Treatment Failure
    Kumar NP, Moideen K, Nancy A, Viswanathan V, Thiruvengadam K, Sivakumar S, Hissar S, Kornfeld H, Babu S.. Front Immunol. 2021 Nov 15;12:731878. doi: 10.3389/fimmu.2021.731878. PMID: 34867953; PMCID: PMC8634481
  2. Effect of anti-tuberculosis treatment on the systemic levels of tissue inhibitors of metalloproteinases in tuberculosis – Diabetes co-morbidity
    Kumar NP, Moideen K, Viswanathan V, Sivakumar S, Hissar S, Kornfeld H, Babu S.. J Clin Tuberc Other Mycobact Dis. 2021 Apr 22;23:100237. doi: 10.1016/j.jctube.2021.100237. PMID: 33997311; PMCID: PMC8100611.

CMC VELLORE

  1. MTB/RIF Ultra over Xpert® MTB/RIF in the diagnosis of extrapulmonary TB
    D. J. Christopher, V. Coelho, G. S. Ebby, D. Shankar, R. Gupta, B. Thangakunam,
    Departments of Pulmonary Medicine, General Surgery – Unit IV, Gastroenterology, and Respiratory Medicine, Christian Medical College, Vellore, India INT J TUBERC LUNG DIS 25(11):939–944 Q 2021. The Union. Nov 2021.
    DOI: http://dx.doi.org/10.5588/ijtld.21.0280
  2. Deep LF-Net: Semantic lung segmentation from Indian chest radiographs including severely unhealthy images 
    Anushikha Singh a, Brejesh Lall b, B.K. Panigrahi b, Anjali Agrawal c, Anurag Agrawal d, Balamugesh Thangakunam , D.J. Christopher, Biomedical Signal Processing and Control, Apr 2021
    DOI: https://doi.org/10.1016/j.bspc.2021.102666

JIPMER/RUTGERS

  1. Accuracy of Timika X-ray scoring system to predict the treatment outcomes among tuberculosis patients in India.
    Yuvaraj Krishnamoorthy, Selby Knudsen, Sathish Rajaa, Subitha Lakshminarayanan, P.B. Senbagavalli, Jerrold Ellner, Charles Horsburgh, Natasha Hochberg, Padmini Salgame, Sonali Sarkar. IJTB (in press) Received 18 September 2020, Accepted 4 August 2021, Available online 11 August 2021. https://doi.org/10.1016/j.ijtb.2021.08.004.
  2. Tuberculosis-Learning the Impact of Nutrition (TB LION): protocol for an interventional study to decrease TB risk in household contacts.
    Cintron C, Narasimhan PB, Locks L, Babu S, Sinha P, Rajkumari N, Kaipilyawar V, Bhargava A, Maloomian K, Chandrasekaran P, Verma S, Joseph N, Johnson WE, Wanke C, Horsburgh CR Jr, Ellner JJ, Sarkar S, Salgame P, Lakshminarayanan S, Hochberg NS. BMC Infect Dis. 2021 Oct 12;21(1):1058. doi: 10.1186/s12879-021-06734-z.
  3. Comparison of profile and treatment outcomes between elderly and non-elderly tuberculosis patients in Puducherry and Tamil Nadu, South India.
    Murali S, Krishnamoorthy Y, Knudsen S, Roy G, Ellner J, Horsburgh CR, Hochberg N, Salgame P, Prakash Babu S, Sarkar S. PLoS One. 2021 Aug 27;16(8): e0256773.
  4. Prevalence and factors associated with diabetes mellitus among tuberculosis patients in South India—a cross-sectional analytical study.
    Sathish Rajaa, Yuvaraj Krishnamoorthy, Selby Knudsen, Gautam Roy, Jerrold Ellner, Charles Horsburgh, Natasha Hochberg, Padmini Salgame, Govindarajan S, Senbagavalli Prakash Babu, Sonali Sarkar. BMJ Open 2021;11:e050542. doi: 10.1136/bmjopen-2021-050542
  5. ‘People listen more to what actors say’: A qualitative study of tuberculosis-related knowledge, behaviours, stigma, and potential interventions in Puducherry, India.
    Sabin LL, Thulasingam M, Carwile M, Babu SP, Knudsen S, Dong L, Stephens J, Fernandes P, Cintron C, Horsburgh CR, Salgame P, Ellner JJ, Sarkar S, Hochberg NS. Glob Public Health. 2021 Oct 16:1-13.
  6. Prevalence and Risk Factors associated with Latent Tuberculosis Infection among Household Contacts of Smear Positive Pulmonary Tuberculosis patients in South India.
    Krishnamoorthy Y, Ezhumalai K, Murali S, Rajaa S, Jose M, Sathishkumar A, Govindarajan S, Horsburgh C, Hochberg N, Johnson E, Knudsen S. Tropical Medicine & International Health. 2021 Oct 15. https://doi.org/10.1111/tmi.13693
  7. Reasons for refusal among patients with tuberculosis and their household contacts to participate in an observational cohort study.
    Raghupathy Kalaivani, Knudsen Selby, Ellner Jerrold, Horsburg Charles, Hochberg Natasha, Salgame Padmini, Chinnakali Palanivel, Prakashbabu Senbagavalli, Sarkar Sonali. Perspect Clin Res. 2021 Oct-Dec;12(4):234-235. doi: 10.4103/picr. Epub 2021 Sep 20. PMID: 34760653; PMCID: PMC8525795.
  8. Severe undernutrition in children affects tuberculin skin test performance in Southern India.
    Reddy D, Ma Y, Lakshminarayanan S, Sahu S, White LF, Reshma A, Roy G, Salgame P, Knudsen S, Cintron C, Ellner JJ, Horsburgh CR Jr, Sarkar S, Hochberg NS. Severe undernutrition in children affects tuberculin skin test performance in Southern India. PLoS One. 2021 Jul 16;16(7):e0250304. doi: 10.1371/journal.pone.0250304. PMID: 34270546; PMCID: PMC8284816.
  9. Comparing Tuberculosis Gene Signatures in Malnourished Individuals using the TBSignatureProfiler
    Johnson WE, Odom A, Cintron C, Muthaiah M, Knudsen S, Joseph N, Jenkins DF, , Babu S, Lakshminarayanan S, Zhao Y, Nankya E, Horsburgh CR Jr, Roy G, Ellner JJ, Sarkar S, Salgame P*, Hochberg NS. BMC Inf Dis 2021; 21(1):106. PMID: 33482742.
  10. Health-related quality of life and its effect on TB treatment outcomes.
    Roy N, Krishnamoorthy Y, Rajaa S, Ezhumalai K, Madhusudhanan S, Raghupathy K, Knudsen S, Horsburgh CR, Hochberg NS, Salgame P, Ellner J, Subitha L, Babu SP, Sarkar S. The International Journal of Tuberculosis and Lung Disease, Volume 25 (4) 1 April 2021, pp. 318-320(3) PMID: 33762076. DOI: 10.5588/ijtld.20.0722

BMMRC

  1. Defective expansion and function of memory like natural killer cells in HIV+ individuals with latent tuberculosis infection. Kamakshi Prudhula Devalraju, Venkata Sanjeev Kumar Neela, Siva Sai Krovvidi, Ramakrishna Vankayalapati, Vijaya Lakshmi Valluri PLoS ONE 16(9): e0257185.
  2. Reduced thyroxine production in young household contacts of tuberculosis patients increases active tuberculosis disease risk
    Devalraju KP, Tripathi D, Neela VSK, Paidipally P, Bogam AK, Mallidi V, Sykam A, Singh KP, Ansari MS, Vankayalapati R, Valluri VL. JCI Insight. 2021;6(13):e148271.

BJGMC/ CTRIUMPH

  1. Unhealthy alcohol use is independently associated with unfavorable TB treatment outcomes among Indian men.
    Cox SR, Gupte AN, Thomas B, Gaikwad S, Mave V, Padmapriyadarsini C, Sahasrabudhe TR, Kadam D, Gupte N, Hanna LE, Kagal A, Paradkar M, Thiruvengadam K, Jain D, Atre S, Sekar K, Raskar S, Shivakumar SVBY, Santhappan R, Deshmukh S, Pradhan N, Kulkarni V, Kakrani A, Barthwal MS, Sawant T, DeLuca A, Suryavanshi N, Chander G, Bollinger R, Golub JE, Gupta A. doi: 10.5588/ijtld.20.0778. PMID: 33688806.
  2. Host Lipidome Predicts Tuberculosis Treatment Failure
    Rupak Shivakoti, John W Newman, Luke Elizabeth Hanna, Artur T L Queiroz, Kamil Borkowski, Akshay N Gupte, Mandar Paradkar, Pattabiraman Satyamurthi, Vandana Kulkarni, Murugesh Selva, Neeta Pradhan, Shri Vijay Bala Yogendra Shivakumar, Saravanan Natarajan, Ramesh Karunaianatham, Nikhil Gupte, Kannan Thiruvengadam, Oliver Fiehn, Renu Bharadwaj, Anju Kagal, Sanjay Gaikwad, Shashikala Sangle, Jonathan E. Golub, Bruno B Andrade, Vidya Mave, Amita Gupta, Padmapriyadarshini Chandrasekaran. DOI: 10.1183/13993003.04532-2020
  3. Baseline IL-6 is a biomarker for unfavorable tuberculosis treatment outcomes: a multi-site discovery and validation study
    Akshay N. Gupte, Pavan Kumar, Mariana Araújo-Pereira, Vandana Kulkarni, Mandar Paradkar, Neeta Pradhan, Padmapriya Darasini, Luke Hanna, Shri Vijay Bala Yogendra Shivakumar, Neesha Rockwood, Elsa Du Bruyn, Rajesh Karyakarte, Sanjay Gaikwad, Robert Bollinger, Jonathan Golub, Nikhil Gupte, Vijay Viswanathan, Robert J. Wilkinson, Vidya Mave, Subash Babu, Hardy Kornfeld, Bruno B. Andrade, Amita Gupta.
  4. Concomitant Pulmonary Disease is Common among Indian Patients With Extrapulmonary Tuberculosis.
    Shri Vijay Bala Yogendra, Shivakumar, Chandrasekaran Padmapriyadarshini, Amol Chavan, Mandar Paradkar, BM Shrinivasa, Akshay Gupte, Kavitha Dhanasekaran, Beena Thomas, Nishi Suryavanshi, Chandra Kumar Dolla, Sriram Selvaraju, Aarti Kinikar, Sanjay Gaikwad, Rewa Kholi, Gomathi Narayan Sivaramakrishnan, Neeta Pradhan, Luke Elizabeth Hanna, Vandana Kulkarni, Andrea DeLuca, Samyra R. Cox, Lakshmi Murali, Kannan Thiruvengadam, Swapnil Raskar, Geeta Ramachandran, Jonathan E. Golub, Nikhil Gupte, Vidya Mave, Soumya Swaminathan MD, Amita Gupta, Robert C Bollinger for the CTRIUMPh-RePORT India Study Team.
  5. Whole Genome Sequencing Assessing Impact of Diabetes Mellitus on Tuberculosis Mutations and Type of Recurrence in India
    Vidya Mave, Liang Chen, Umadevi Ranganathan, Dileep Kadam, Rahul Lokhande, Shivkumar, Anju Kagal, Neeta Pradhan, Vijay Vishwanathan, Amita Gupta, Padmapriyadarshini, Jonathan E. Golub, Nikhil Gupte, Barun Mathema, Barry Kreiswirth.
  6. Modern lineages of Mycobacterium tuberculosis were recently introduced in western India and demonstrate increased transmissibility
    Avika Dixit, Anju Kagal, Yasha Ektefaie, Luca Freschi, Rahul Lokhande, Matthias Groeschel, Jeffrey A. Tornheim, Nikhil Gupte, Neeta Pradhan, Deelip Kadam, Marco Schito, David Engelthaler, Amita Gupta, Jonathan Golub, Vidya Mave, Maha Farhat.
  7. Sex differences in tuberculosis clinical presentation, drug exposure, and treatment outcomes in Pune, India.
    Sona Deshmukh, Manasi Sane, Sanjay Gaikwad, Tushar Sahasrabudhe, Madhusudan Barthwal, Rahul Lokhande, Swapnil Raskar, Anju Kagal, Sujata Dharmshale, Neeta Pradhan, Akshay Gupte, Omamah Alfarisi, Amita Gupta, Kelly E. Dooley, Nikhil Gupte, Jonathan E. Golub, Vidya Mave.

2021

BRAZIL
  1. Costa AG, Carvalho BKS, Araújo-Pereira M, Ibiapina HNS, Spener-Gomes R, Souza AB, Gomes-Silva A, Andrade AMS, Silva EC, Arriaga MB, Benjamin A, Rocha MS, Moreira ASR, Oliveira JG, Figueiredo MC, Turner MM, Durovni B, Cavalcante S, Kritski AL, Rolla VC, Sterling TR, Andrade BB, Cordeiro-Santos M; RePORT-Brazil Consortium. Lessons Learned from Implementation of an Interferon Gamma Release Assay to Screen for Latent Tuberculosis Infection in a Large Multicenter Observational Cohort Study in Brazil. Microbiol Spectr. 2021 Dec 1:e0116321. doi: 10.1128/Spectrum.01163-21. Epub ahead of print. PMID: 34851140.
  2. Arriaga MB, Araújo-Pereira M, Barreto-Duarte B, Nogueira B, Freire MVCNS, Queiroz ATL, Rodrigues MMS, Rocha MS, Souza AB, Spener-Gomes R, Carvalho ACC, Figueiredo MC, Turner MM, Durovni B, Lapa-E-Silva JR, Kritski AL, Cavalcante S, Rolla VC, Cordeiro-Santos M, Sterling TR, Andrade BB; RePORT Brazil consortium. The Effect of Diabetes and Prediabetes on Anti-tuberculosis Treatment Outcomes: A Multi-center Prospective Cohort Study. J Infect Dis. 2021 Oct 15:jiab427. doi: 10.1093/infdis/jiab427. Epub ahead of print. PMID: 34651642.
  3. Souza AB, Arriaga MB, Amorim G, Araújo-Pereira M, Nogueira BMF, Queiroz ATL, Figueiredo MC, Rocha MS, Benjamin A, Moreira ASR, Oliveira JG, Rolla V, Durovni B, Lapa E Silva JR, Kritski AL, Cavalcante S, Sterling T, Andrade BB, Cordeiro-Santos M; RePORT Brazil consortium. Determinants of losses in the latent tuberculosis infection cascade of care in Brazil. BMJ Glob Health. 2021 Sep;6(9):e005969. doi: 10.1136/bmjgh-2021-005969. PMID: 34518204.
  4. Barreto-Duarte B, Araújo-Pereira M, Nogueira BMF, Sobral L, Rodrigues MMS, Queiroz ATL, Rocha MS, Nascimento V, Souza AB, Cordeiro-Santos M, Kritski AL, Sterling TR, Arriaga MB, Andrade BB. Tuberculosis Burden and Determinants of Treatment Outcomes According to Age in Brazil: A Nationwide Study of 896,314 Cases Reported Between 2010 and 2019. Front Med (Lausanne). 2021 Jul 27;8:706689. doi: 10.3389/fmed.2021.706689. PMID: 34386510; PMCID: PMC8354381.
  5. Carvalho ACC, Amorim G, Melo MGM, Silveira AKA, Vargas PHL, Moreira ASR, Rocha MS, Souza AB, Arriaga MB, Araújo-Pereira M, Figueiredo MC, Durovni B, Lapa-E-Silva JR, Cavalcante S, Rolla VC, Sterling TR, Cordeiro-Santos M, Andrade BB, Silva EC, Kritski AL; RePORT Brazil consortium. Pre-Treatment Neutrophil Count as a Predictor of Antituberculosis Therapy Outcomes: A Multicenter Prospective Cohort Study. Front Immunol. 2021 Jul 2;12:661934. doi: 10.3389/fimmu.2021.661934. PMID: 34276654; PMCID: PMC8284392.
  6. Peetluk LS, Rebeiro PF, Ridolfi FM, Andrade BB, Cordeiro-Santos M, Kritski A, Durovni B, Calvacante S, Figueiredo MC, Haas DW, Liu D, Rolla VC, Sterling TR; Regional Prospective Observational Research in Tuberculosis (RePORT)-Brazil network. A clinical prediction model for unsuccessful pulmonary tuberculosis treatment outcomes. Clin Infect Dis. 2021 Jul 2:ciab598. doi: 10.1093/cid/ciab598. Epub ahead of print. PMID: 34214166.
  7. Arriaga MB, Rocha MS, Nogueira B, Nascimento V, Araújo-Pereira M, Souza AB, Andrade AMS, Costa AG, Gomes-Silva A, Silva EC, Figueiredo MC, Turner MM, Durovni B, Lapa-E-Silva JR, Kritski AL, Cavalcante S, Rolla VC, Cordeiro-Santos M, Sterling TR, Andrade BB; RePORT Brazil consortium. The Effect of Diabetes and Prediabetes on Mycobacterium tuberculosis Transmission to Close Contacts. J Infect Dis. 2021 May 19:jiab264. doi: 10.1093/infdis/jiab264. Epub ahead of print. PMID: 34008010
  8. Kulkarni V, Queiroz ATL, Sangle S, Kagal A, Salvi S, Gupta A, Ellner J, Kadam D, Rolla VC, Andrade BB, Salgame P, Mave V. A Two-Gene Signature for Tuberculosis Diagnosis in Persons With Advanced HIV. Front Immunol. 2021 Feb 22;12:631165. doi: 10.3389/fimmu.2021.631165. PMID: 33692804; PMCID: PMC7937880.
  9. Spener-Gomes R, Costa AG, Melo HF, Souza AB, Beraldi-Magalhães F, Jesus JS, Arriaga MB, Kritski A, Safe I, Andrade BB, Trajman A, Cordeiro-Santos M. Examination of respiratory specimens improves microbiological diagnosis of patients with presumptive extrapulmonary tuberculosis. IJID. 2021 Mar 12; doi: 10.1016/j.ijid.2021.03.022. PMID: 33722683.
  10. Peetluk LS, Ridolfi FM, Rebeiro PF, Liu D, Rolla VC, Sterling TR. Systematic review of prediction models for pulmonary tuberculosis treatment outcomes in adults. BMJ Open. 2021 Mar 2;11(3):e044687. doi: 10.1136/bmjopen-2020-044687. PMID: 33653759; PMCID: PMC7929865.
INDIA
  1. Deep LF-Net: Semantic lung segmentation from Indian chest radiographs including severely unhealthy images
    Anushikha Singh, Brejesh Lall, BK Panigrahi, Anjali Agrawal, Anurag Agrawal, Balamugesh Thangakunam, DJ Christopher, Biomedical Signal Processing and Control, https://doi.org/10.1016/j.bspc.2021.102666.
  2. Measuring tuberculosis drugs in hair in adults and children as a tool to monitor exposure and outcomes
    Mave V, Kadam D, Gaikwad S, Kinikar A, Aguilar D, Chavan A, Paradkar M, Shivakumar SVBY, Bharadwaj R, Kagal A, Suryavanshi N, Golub J, Kulkarni V, Dooley K, Gupta A, Bachetti P, Gerona R, Gupte N, Gandhi M. Int J Tuberc Lung Dis. 2021 Jan 1;25(1):52-60. doi: 10.5588/ijtld.20.0574. PMID: 33384045.
  3. Potential drug-drug interactions between anti–tubercular and non-tubercular drugs among patients with pulmonary tuberculosis in Puducherry and Tamil Nadu
    Marie CJ, Senbagavalli PB, Ezhumalai K, Knudsen S, Horsburgh CR, Hochberg NS, Salgame P, Ellner J, Sarkar S. European Journal of Pharmaceutical and Medical Research. 2021;8(1), 427-440.
  4. Comparing tuberculosis gene signatures in malnourished individuals using the TBSignatureProfiler
    Johnson WE, Odom A , Cintron C, Muthaiah M, Knudsen S , Joseph N, Prakash Babu S, Lakshminarayanan S, Jenkins DF, Zhao Y, Nankya E, Horsburgh CR, Roy G, Ellner J, Sarkar S, Salgame P, Hochberg NS. BMC Infect Dis. 2021 Jan 22;21(1):106. doi: 10.1186/s12879-020-05598-z. PMID: 33482742; PMCID: PMC7821401.
  5. Food for thought: addressing undernutrition to end TB
    Sinha P, Lönnroth K, Bhargava A, Heysell SK, Sarkar S, Salgame P, Rudgard W, Boccia D, Van Aartsen D, Hochberg NS. Lancet Infectious Diseases. 2020 (Accepted, in press)
  6. Physical health-related quality of life and its effect on treatment outcomes among pulmonary tuberculosis patients
    Roy N, Krishnamoorthy Y, Rajaa S, Ezhumalai K, Madhusudhanan S, Raghupathy K, Knudsen S, Horsburgh CR, Hochberg NS, Salgame P, Ellner J, Subitha L, Babu SP, Sarkar S. Health-related quality of life and its effect on TB treatment outcomes. Int J Tuberc Lung Dis. 2021 Apr 1;25(4):318-320.
  7. Reasons for refusal among patients with tuberculosis and their household contacts to participate in an observational cohort study
    Raghupathy K , Knudsen S, Ellner J, Horsburgh RC, Hochberg N, Salgame P, Chinnakali P, Prakashbabu P, Sarkar S. (Accepted: Perspectives in Clinical Research, 2021)
  8. Unhealthy alcohol use independently associated with unfavorable tuberculosis treatment outcomes among Indian men
    Cox SR, Gupte AN, Thomas B, Gaikwad S, Mave V, Padmapriyadarsini C, Sahasrabudhe RT, Kadam D, Gupte N, Hanna LE, Kagal A, Paradkar M, Thiruvengadam K, Jain D, Atre S, Sekar K, Raskar S, Shivakumar SVBY, Santhappan R, Deshmukh S, Pradhan N, Kulkarni V, Kakrani A, Barathwal MS, Sawant T, Deluca A, Suryavanshi N, Chander G, Bollinger R, Golub JE, Gupta A. (Accepted: IJTLD)
  9. A two-gene signature for tuberculosis diagnosis in persons with advanced HIV
    Kulkarni V, Queiroz ATL, Sangle S, Kagal A, Salvi S, Gupta A, Ellner J, Kadam D, Rolla VC, Andrade BB, Salgame P, Mave V. (Accepted: Frontiers in Immunology)
  10. Substantial early mortality among tuberculosis patients with diabetes mellitus, particularly among patients not receiving metformin, in India
    Mave V, Gaikwad S, Barthwal M, Chandanwale A, Lokhande R, Kadam D, Dharmshale S, Bharadwaj R, Kagal A, Pradhan N, Deshmukh S, Atre S, Sahasrabudhe T, Meshram S, Kakrani A, Kulkarni V, Raskar S, Suryavanshi N, Kornfeld H, Dooley KE, Chon S, Gupte A, Gupta A, Gupte N, Golub JE. (Accepted: OFID)
philippines
  1. Poblete J, Montoya J, Ang C, Rivera P, Kato S, Keicho N, Maeda S, Miyabayashi A, Lopez AL, Aldaba J, et al. Genetic diversity of Mycobacterium tuberculosis Isolates from a Rural Community in the Philippines. Phil Journal of Science 2021; 150(4): 669-78

     

  2. Lansang MAD, Alejandria MM, Law I, Juban NR, Amarillo MLE, Sison OT, et al. High TB burden and low notification rates in the Philippines: The 2016 national TB prevalence survey. High TB burden and low notification rates in the Philippines: The 2016 national TB prevalence survey. PLoS ONE 2021; 16(6): e0252240. https://doi. org/10.1371/journal.pone.0252240

     

  3. Malabad J, Ang C, Cajucom M, Palabrica F, Gloriani N, Villanueva S, Montoya J. Molecular Epidemiology of Mycobacterium tuberculosis in Adult Filipino TB/HIV Co-infected Patients. Int J Tuberc Lung Dis 2021; 25(4):285-291. doi: 10.5588/ijtld.20.0878.

south africa
  1. Mulenga H, Musvosvi M, Mendelsohn SC, Penn-Nicholson A, Kimbung Mbandi S, Fiore-Gartland A, Tameris M, Mabwe S, Africa H, Bilek N, Kafaar F, Khader SA, Carstens B, Hadley K, Hikuam C, Erasmus M, Jaxa L, Raphela R, Nombida O, Kaskar M, Nicol MP, Mbhele S, Van Heerden J, Innes C, Brumskine W, Hiemstra A, Malherbe ST, Hassan-Moosa R, Walzl G, Naidoo K, Churchyard G, Hatherill M, Scriba TJ; CORTIS Study Team.Am J Respir Crit Care Med. 2021 Dec 15;204(12):1463-1472. doi: 10.1164/rccm.202103-0548OC.PMID: 34520313
  2. Nicol MP, Schumacher SG, Workman L, Broger T, Baard C, Prins M, Bateman L, du Toit E, van Heerden J, Szekely R, Zar HJ, Denkinger CM. Accuracy of a Novel Urine Test, Fujifilm SILVAMP Tuberculosis Lipoarabinomannan, for the Diagnosis of Pulmonary Tuberculosis in Children. Clin Infect Dis. 2021 May 4;72(9):e280-e288. doi: 10.1093/cid/ciaa1052.

2020

BRAZIL
  1. Barreto-Duarte B, Sterling TR, Fiske CT, Almeida A, Nochowicz CH, Smith RM, Barnett L, Warren C, Blackman A, Lapa E Silva JR, Andrade BB, Kalams SA. Increased Frequency of Memory CD4+ T-Cell Responses in Individuals With Previously Treated Extrapulmonary Tuberculosis. Front Immunol. 2020 Dec 17;11:605338. doi: 10.3389/fimmu.2020.605338. PMID: 33391271; PMCID: PMC7774017.
  2. Arriaga MB, Amorim G, Queiroz ATL, Rodrigues MMS, Araújo-Pereira M, Nogueira BMF, Souza AB, Rocha MS, Benjamin A, Moreira ASR, de Oliveira JG, Figueiredo MC, Turner MM, Alves K, Durovni B, Lapa-E-Silva JR, Kritski AL, Cavalcante S, Rolla VC, Cordeiro-Santos M, Sterling TR, Andrade BB; RePORT Brazil consortium. Novel stepwise approach to assess representativeness of a large multicenter observational cohort of tuberculosis patients: The example of RePORT Brazil. Int J Infect Dis. 2021 Feb;103:110-118. doi: 10.1016/j.ijid.2020.11.140. Epub 2020 Nov 14. PMID: 33197582; PMCID: PMC7959330.
  3. Silveira-Mattos PS, Barreto-Duarte B, Vasconcelos B, Fukutani KF, Vinhaes CL, Oliveira-De-Souza D, Ibegbu CC, Figueiredo MC, Sterling TR, Rengarajan J, Andrade BB. Differential Expression of Activation Markers by Mycobacterium tuberculosis-specific CD4+ T Cell Distinguishes Extrapulmonary From Pulmonary Tuberculosis and Latent Infection. Clin Infect Dis. 2020 Nov 5;71(8):1905-1911. doi: 10.1093/cid/ciz1070. PMID: 31665254.
  4. Demitto FO, Araújo-Pereira M, Schmaltz CA, Sant’Anna FM, Arriaga MB, Andrade BB, Rolla VC. Impact of Persistent Anemia on Systemic Inflammation and Tuberculosis Outcomes in Persons Living With HIV. Front Immunol. 2020 Sep 24;11:588405. doi: 10.3389/fimmu.2020.588405. PMID: 33072136; PMCID: PMC7541849.
  5. Rebeiro PF, Cohen MJ, Ewing HM, Figueiredo MC, Peetluk LS, Andrade KB, Eakin M, Zechmeister EJ, Sterling TR. Knowledge and stigma of latent tuberculosis infection in Brazil: implications for tuberculosis prevention strategies. BMC Public Health. 2020 Jun 9;20(1):897. doi: 10.1186/s12889-020-09053-1. PMID: 32517671; PMCID: PMC7285569.
  6. Penn-Nicholson A, Mbandi SK, Thompson E, Mendelsohn SC, Suliman S, Chegou NN, Malherbe ST, Darboe F, Erasmus M, Hanekom WA, Bilek N, Fisher M, Kaufmann SHE, Winter J, Murphy M, Wood R, Morrow C, Van Rhijn I, Moody B, Murray M, Andrade BB, Sterling TR, Sutherland J, Naidoo K, Padayatchi N, Walzl G, Hatherill M, Zak D, Scriba TJ; Adolescent Cohort Study team; GC6-74 Consortium; SATVI Clinical and Laboratory Team; ScreenTB Consortium; AE-TBC Consortium; RePORT Brazil Team; Peruvian Household Contacts Cohort Team; CAPRISA IMPRESS team. RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response. Sci Rep. 2020 May 25;10(1):8629. doi: 10.1038/s41598-020-65043-8. PMID: 32451443; PMCID: PMC7248089.
  7. Peetluk LS, Rebeiro PF, Cordeiro-Santos M, Kritski A, Andrade BB, Durovni B, Calvacante S, Arriaga MB, Turner MM, Figueiredo MC, Rolla VC, Sterling TR. Lack of Weight Gain During the First 2 Months of Treatment and Human Immunodeficiency Virus Independently Predict Unsuccessful Treatment Outcomes in Tuberculosis. J Infect Dis. 2020 Apr 7;221(9):1416-1424. doi: 10.1093/infdis/jiz595. PMID: 31724035; PMCID: PMC7137883.
  8. Cubillos-Angulo JM, Arriaga MB, Melo MGM, Silva EC, Alvarado-Arnez LE, de Almeida AS, Moraes MO, Moreira ASR, Lapa E Silva JR, Fukutani KF, Sterling TR, Hawn TR, Kritski AL, Oliveira MM, Andrade BB. Polymorphisms in interferon pathway genes and risk of Mycobacterium tuberculosis infection in contacts of tuberculosis cases in Brazil. Int J Infect Dis. 2020 Mar;92:21-28. doi: 10.1016/j.ijid.2019.12.013. Epub 2019 Dec 13. PMID: 31843671; PMCID: PMC7197195.
INDIA
  1. Integration of metabolomics and transcriptomics reveals novel biomarkers in the blood for tuberculosis diagnosis in children
    Dutta NK, Tornheim JA, Fukutani KF, Paradkar M, Tiburcio RT, Kinikar A, Valvi C, Kulkarni V, Pradhan N, Shivakumar SVBY, Kagal A, Gupte A, Gupte N, Mave V, Gupta A, Andrade BB, Karakousis PC for the CTRIUMPh RePORT India Study Team. Scientific Reports. 2020 Nov 11;10(19527). PMID: 33177551; PMCID: PMC7658223.
  2. Assessment of persistent depressive symptoms among tuberculosis patients in India
    Suryavanshi N, Sane M, Gaikwad S, Paradkar M, Mave V, Padmapriyadarsini C, Shivakumar SVBY, Gupta A, Gupte N, Thomas B for CTRIUMPH RePORT India study. IJTLD. 2020 Nov 1;24(11):1208-1211(4). PMID: 33172530.
  3. Higher IL-6 levels and changes in TGF-β are associated with lung impairment in pulmonary tuberculosis
    Gupte AN, Selvaraju S, Gaikwad S, Mave V, Kumar P, Babu S, Andrade BB, Checkley W, Bollinger R, Gupta A for the CTRIUMPH study team. ERJ Open Research. 2020 September. DOI: 10.1183/23120541.00390-2020.
  4. Tuberculosis preventive treatment should be considered for all household contacts of pulmonary TB patients in India
    Paradkar M, Padmapriyadarsini C, Jain D, Shivakumar SVBY, Thiruvengadam K, Gupte AN, Thomas B, Kinikar A, Sekar K, Bharadwaj B, Dolla CK, Gaikwad S, Elilarasi S, Lokhande R, Reddy D, Murali L, Kulkarni V, Pradhan N, Elizabeth Hanna L, Pattabiraman S, Kohli1 R, Nayagam R, Suryavanshi1 N, Shrinivasa BM, Cox SR, Sriram Selvaraju S, Gupte N, Mave V, Gupta A, Bollinger RC, for the CTRIUMPH-RePORT India Study Team. PLOS One. 2020 July 29;15(7):e0236743. https://doi.org/10.1371/journal.pone.0236743. PMID: 32726367; PMCID: PMC7390377.
  5. Xpert Ultra is better than Xpert, but using biopsy, samples may be even better
    Thangakunam B, Christopher DJ. Chest. 2020 Aug;158(2):829-830. doi: 10.1016/j.chest.2020.02.078. PMID: 32768069
  6. Screening for prevalence of current TB disease and latent TB infection in type 2 diabetes mellitus patients attending a diabetic clinic in an Indian tertiary care hospital
    Dabhi PA, Thangakunam B, Prince J, Gupta R, Nihal T, Naik D, Christopher DJ. PLoS One. 2020 Jun 5;15(6):e0233385. doi: 10.1371/journal.pone.0233385. eCollection 2020. PMID: 32502176; PMCID: PMC7274437.
  7. Burden of diabetes among patients with tuberculosis: 10-year experience from a tertiary care referral teaching hospital in South India
    Christopher DJ, Jeyaseelan L, Michael JS, Veeraraghavan B, Manipadam MT, David T, Gupta M, Yadav B. Lung India. May-Jun 2020;37(3):232-237. doi: 10.4103/lungindia.lungindia_111_19. PMID: 32367845; PMCID: PMC7353927.
  8. Is routine pre-entry chest radiograph necessary in a high tuberculosis prevalence country?
    Jasper A, Gibikote S, Kirupakaran H, Christopher DJ, Mathews P. J Postgrad Med. Apr-Jun 2020;66(2):90-93. doi: 10.4103/jpgm.JPGM_462_19. PMID: 32270779; PMCID: PMC7239409.
  9. How much do Indians pay for tuberculosis treatment? A cost analysis
    Sinha P, Carwile M, Bhargava A, Cintron C, Acuna-Villaorduna C, Lakshminarayanan S, Kulatilaka N, Locks L, Hochberg NS. Public Health Action. 2020 Sep 21;10(3):110-117. doi: 10.5588/pha.20.0017. PMID: 33134125; PMCID: PMC7577002.
  10. Risk factors for death during treatment in pulmonary tuberculosis patients in South India: A cohort study
    Ramakrishnan J, Sarkar S, Chinnakali P, Lakshminarayanan S, Sahu S, Reshma A, et al. Indian Journal of Tuberculosis. 2020 Oct.
  11. Neonatal tetanus in a nomadic population in South India: A clinicosocial case study
    Surendran G, Rehman T, Eliyas S, Kalaiselvy A, Sarkar S. Indian Journal of Community Medicine. 2020 Jul 1;45(3):384.
  12. Oft-overlooked: controlling for undernutrition in epidemiological studies of tuberculosis
    Sinha P, Hochberg NS. Letter to the Editor. Lancet Infectious Diseases 2020; 20(5);540-541.
  13. Household food insecurity among patients with pulmonary tuberculosis and its associated factors in South India: a cross-sectional analysis
    Ayiraveetil R, Sarkar S, Chinnakali P, Jeyashree K, Vijayageetha M, Thekkur P, Lakshminarayanan S, Knudsen S, Hochberg NS, Horsburgh CR, Ellner J, Roy G. BMJ Open. 2020 Feb 28;10(2):e033798; PMID: 32114470 ; PMCID: PMC7050349.
  14. Predictors of loss to follow-up among male tuberculosis cases in Pondicherry and Tamil Nadu, India
    Zhou T, Lakshminarayanan S, Sarkar S, Knudsen S, Horsburgh CR Jr, Muthaiah M, Kan C, Salgame P, Ellner J, Roy G, Jenkins H, Hochberg NS. Am J Trop Med Hygiene; 2020. 103(3): 1050-56.
  15. Evaluation of factors influencing Mycobacterium tuberculosis complex recovery and contamination rates in MGIT960
    Ellappan K, Datta S, Muthuraj M, Lakshminarayanan S, Pleskunas JA, Horsburgh CR Jr, Salgame P, Hochberg N, Sarkar S, Ellner JJ, Roy G, Jose M, Vinod Kumar S, Joseph NM. Indian J Tuberculosis; 2020; published online 19 July. https://doi.org/10.1016/j.ijtb.2020.07.016.
  16. Controlling for undernutrition in epidemiological studies of tuberculosis
    Sinha P, Hochberg NS. Lancet Infectious Diseases. 2020, 20(5): 540-541. PMID: 32359465.
  17. MAL adaptor (TIRAP) S180L polymorphism and severity of disease among tuberculosis patients
    Saranathan R, Sathyamurthi P, Thiruvengadam K, Murugesan S, Shivakumar SVBY, NS Gomathi, Kavitha D, Paradkar M, Puvaneshwari R, Kannan M, Madheswaran A, Pradhan N, Kulkarni V, Gupte AN, Gupte N, Mave V, Bollinger RC, Gupta A, Padmapriyadarsini C, Hanna LE. Infection, Genetics, and Evolution. 2020 Jan(44). Epub ahead of print 2019 Oct 31. PMID: 31678649.
  18. Association of plasma matrix metalloproteinase and tissue inhibitors of matrix metalloproteinase levels with adverse treatment outcomes among patients with pulmonary tuberculosis
    Kumar NP, Moideen K, Nancy A, Viswanathan V, Thiruvengadam K, Sivakumar S, Hissar S, Nair D, Banurekha VV, Kornfeld H, Babu S. JAMA Netw Open. 2020 Dec 1;3(12):e2027754. PMID: 33258908.
  19. Plasma chemokines are baseline predictors of unfavorable treatment outcomes in pulmonary tuberculosis
    Kumar NP, Moideen K, Nancy A, Viswanathan V, Thiruvengadam K, Nair C, Banurekha VV, Sivakumar S, Hissar S, Kornfeld H, Babu S. Clin Infect Dis. 2020 Aug 07;ciaa1104, https://doi.org/10.1093/cid/ciaa1104. PMID: 31472402.
  20. Heterogeneity in the cytokine profile of tuberculosis-diabetes co-morbidity
    Kumar NP, Moideen K, Nancy A, Viswanathan V, Shruthi BS, Sivakumar S, Natarajan M, Kornfeld H, Babu S. Cytokine 2020 Jan;125:154824. PMID: 31472402.
  21. Impact of diabetes and low body mass index on tuberculosis treatment outcomes
    Kornfeld H, Sahukar BS, Procter-Gray E, Kumar NP, West K, Kane K, Natarajan M, Li W, Babu S, Viswanathan V. Clin Infect Dis. 2020 Jan 19. pii: ciaa054. doi: 10.1093/cid/ciaa054. [Epub ahead of print]. PMID: 31955202.
  22. Clinical features associated with linezolid resistance among multidrug resistant tuberculosis patients at a tertiary care hospital in Mumbai, India
    Tornheim JA, Intini E, Gupta A, Udwadia ZFJ Clin Tuberc Other Mycobact Dis. 2020 Jul 24;20:100175. doi: 10.1016/j.jctube.2020.100175. eCollection 2020 Aug. PMID: 32775702; PMCID: PMC7398971.
  23. COVID-19 -Tuberculosis interactions: When dark forces collide
    Udwadia ZF, Vora A, Tripathi AR, Malu KN, Lange C, Saru Raju R. Indian J Tuberc. 2020 Dec;67(4S):S155-S162. doi: 10.1016/j.ijtb.2020.07.003. Epub 2020 Jul 15. PMID: 33308662; PMCID: PMC7362784.
  24. Whole genome enrichment approach for rapid detection of Mycobacterium tuberculosis and drug resistance-associated mutations from direct sputum sequencing
    Soundararajan L , Kambli P , Priyadarshini S, Let B , Murugan S, Iravatham C, Tornheim JA ,Rodrigues C, Gupta R , Ramprasad VL. Tuberculosis (Edinb). 2020 Mar;121:101915. doi: 10.1016/j.tube.2020.101915. Epub 2020 Feb 20. PMID: 32279871.
  25. Toll-like receptor 2 polymorphisms and their effect on the immune response to ESAT-6, Pam3CSK4 TLR2 agonist in pulmonary tuberculosis patients and household contacts
    Mandala JP, Ahmad S, Pullagurla A, Thada S, Joshi L, Ansari MSS, Valluri VL, Gaddam SL. Cytokine. 2020 Feb;126:154897. doi: 10.1016/j.cyto.2019.154897. Epub 2019 Oct 31. PMID: 31678868.
south africa
  1. Lawal IO, Fourie BP, Mathebula M, Moagi I, Lengana T, Moeketsi N, Nchabeleng M, Hatherill M, Sathekge MM. 18F-FDG PET/CT as a Noninvasive Biomarker for Assessing Adequacy of Treatment and Predicting Relapse in Patients Treated for Pulmonary Tuberculosis. J Nucl Med. 2020 Mar;61(3):412-417. doi: 10.2967/jnumed.119.233783. Epub 2019 Aug 26. PMID: 31451489.
  2. Marais BJ, Nicol M, Zar HJ. Key advances and remaining challenges in childhood and adolescent tuberculosis. Paediatr Respir Rev. 2020 Nov;36:25-26. doi: 10.1016/j.prrv.2020.07.008. Epub 2020 Aug 1.
  3.  Nicol MP, Zar HJ. Advances in the diagnosis of pulmonary tuberculosis in children. Paediatr Respir Rev. 2020 Nov;36:52-56. doi: 10.1016/j.prrv.2020.05.003. Epub 2020 May 25.
  4.  Ndlovu LN, Peetluk L, Moodley S, Nhamoyebonde S, Ngoepe AT, Mazibuko M, Khan K, Karim F, Pym AS, Maruri F, Moosa MS, van der Heijden YF, Sterling TR, Leslie A. Increased Neutrophil Count and Decreased Neutrophil CD15 Expression Correlate With TB Disease Severity and Treatment Response Irrespective of HIV Co-infection. Front Immunol. 2020 Aug 28;11:1872. doi: 10.3389/fimmu.2020.01872.
  5.  Beltran CGG, Heunis T, Gallant J, Venter R, du Plessis N, Loxton AG, Trost M, Winter J, Malherbe ST, Kana BD, Walzl G. Investigating Non-sterilizing Cure in TB Patients at the End of Successful Anti-TB Therapy. Front Cell Infect Microbiol. 2020 Aug 25;10:443. doi: 10.3389/fcimb.2020.00443.
  6.  Lawal IO, Fourie BP, Mathebula M, Moagi I, Lengana T, Moeketsi N, Nchabeleng M, Hatherill M, Sathekge MM. <sup>18</sup>F-FDG PET/CT as a Noninvasive Biomarker for Assessing Adequacy of Treatment and Predicting Relapse in Patients Treated for Pulmonary Tuberculosis. J Nucl Med. 2020 Mar;61(3):412-417. doi: 10.2967/jnumed.119.233783. Epub 2019 Aug 26.
  7.  Malherbe ST, Chen RY, Dupont P, Kant I, Kriel M, Loxton AG, Smith B, Beltran CGG, van Zyl S, McAnda S, Abrahams C, Maasdorp E, Doruyter A, Via LE, Barry CE 3rd, Alland D, Richards SG, Ellman A, Peppard T, Belisle J, Tromp G, Ronacher K, Warwick JM, Winter J, Walzl G. Quantitative 18F-FDG PET-CT scan characteristics correlate with tuberculosis treatment response. EJNMMI Res. 2020 Feb 10;10(1):8.doi: 10.1186/s13550-020-0591-9.

2019

BRAZIL
  1. Cubillos-Angulo JM, Arriaga MB, Silva EC, Müller BLA, Ramalho DMP, Fukutani KF, Miranda PFC, Moreira ASR, Ruffino-Netto A, Lapa E Silva JR, Sterling TR, Kritski AL, Oliveira MM, Andrade BB. Polymorphisms in TLR4 and TNFA and Risk of Mycobacterium tuberculosis Infection and Development of Active Disease in Contacts of Tuberculosis Cases in Brazil: A Prospective Cohort Study. Clin Infect Dis. 2019 Aug 30;69(6):1027-1035. doi: 10.1093/cid/ciy1001. PMID: 30481307; PMCID: PMC6735688
INDIA
  1. IL-22 produced by type 3 innate lymphoid cells (ILC3s) reduces the mortality of type 2 diabetes mellitus (T2DM) mice infected with Mycobacterium tuberculosis
    Tripathi D, Radhakrishnan RK, Sivangala TR, Paidipally P, Devalraju KP, Neela VSK, McAllister MK, Samten B, Valluri VL, Vankayalapati R. PLoS Pathog. 2019 Dec 6;15(12):e1008140. PMID: 31809521.
  2. Down regulation of RANTES in pleural site is associated with inhibition of antigen specific response in tuberculosis
    Pydi SS, Ghousunnissa S, Devalraju KP, Ramaseri SS, Gaddam R, Auzumeedi SK, Vankayalapati R, Valluri VL. Tuberculosis (Edinb). 2019 May;116S:S123-S130. PMID: 31103419.
  3. Transcriptomic profiles of confirmed pediatric tuberculosis patients and exposed household contacts identifies tuberculosis disease, infection, and response to treatment among Indian patients
    Tornheim JA, Madugundu A, Paradkar M, Gupte N, Fukutani KF, Gupte AN, Kinikar A, Kulkarni V, Balasubramanian U, Sreenivasamurthy S, Raja R, Pradhan N, Shivakumar SVBY, Valvi C, Hanna LE, Andrade B, Padmapriyadarsini C, Mave V, Pandey A, Gupta A for the CTRIUMPh RePORT India Study Team. J Infect Dis. 2019 Dec 4. pii: jiz639. doi: 10.1093/infdis/jiz639. [Epub ahead of print]. PMID: 31796955.
  4. Lipid mediators of inflammation and resolution in individuals with tuberculosis and tuberculosis-diabetes
    Shivakoti R, Dalli J, Kadam D, Gaikwad S, Barthwal M, Colas RA, Mazzacuva F, Lokhande R, Dharmshale S, Bharadwaj R, Kagal A, Pradhan N, Deshmukh S, Atre S, Sahasrabudhe T, Kakrani A, Kulkarni V, Raskar S, Suryavanshi N, Chon S, Gupte A, Gupta A, Gupte N, Arriaga MB, Fukutani KF, Andrade BB, Golub JE, Mave V. Prostaglandins Other Lipid Mediat. 2019 Nov 11;147:106398. doi: 10.1016/j.prostaglandins.2019.106398. [Epub ahead of print] PMID: 31726221.
  5. Age-specific prevalence of TB infection among household contacts of pulmonary tuberculosis: Is it time for TB preventive therapy?
    Dolla CK , Padmapriyadarsini C, Thiruvengadam K, Lokhande R, Kinikar A, Paradkar M, Gupte A, Gaikwad S, Pradhan N, Kulkarni V, Shivakumar SVBY, Suryavanshi N, Gupte N, Pattabiraman S, Kagal A, Shrinivas BM, Murali L, Bharath TK, Pirthivi M, Kumaran P, Mave V, Gupta A. Trans R Soc Trop Med Hyg. 2019 Oct 11;113(10):632-640. doi: 10.1093/trstmh/trz049. PMID: 31225622; PMCID: PMC6792162.
  6. Delays and barriers to early treatment initiation for childhood tuberculosis in India
    Valvi C, Chandanwale A, Khadse S, Kulkarni R, Kadam D, Kinikar A, Joshi S, Lokhande R, Garg P, Gupte N, Jain D, Suryavanshi N, Golub J, Shankar A, Gupta A, Dhumal G, DeLuca A, Bollinger RC. Int J Tuberc Lung Dis. 2019 Oct 1;23(10):1090-1099. doi: 10.5588/ijtld.18.0439. PMID: 31627774.
  7. Smoking, alcohol use disorder and TB treatment outcomes: A dual co-morbidity burden that cannot be ignored
    Thomas B, Thiruvengadam K, Rani S, Ovung S, Sivakumar S, Shivakumar SVBY, Paradkar M, Gupte N, Suryavanshi N, Gupte AN, Kohli R, Pradhan N, Sivaramakrishnan GN, Gaikwad S, Kagal A, Dhanasekaran K, Deluca A, Golub JE, Mave V, Padmapriyadarsini C, Gupta A, CTRIUMPH-RePORT India Study. PLoS One. 2019 Jul 31;14(7):e0220507. doi: 10.1371/journal.pone.0220507. eCollection 2019. PMID: 31365583; PMCID: PMC6668833.
  8. Infection free “resisters” among household contacts of adult pulmonary tuberculosis
    Mave V, Padmapriyadarsini C, Chavan A, Shivakumar SVBY, Danasekaran K, Paradkar M, Thiruvengadam K, Kinikar A, Murali L, Gaikwad S, Hannah LE, Kulkarni V, Pattabiraman S, Suryavanshi N, Thomas B, Kohli R, Sivaramakrishnan GN, Pradhan N, Banu B, Kagal A, Golub J, Gupte A, Gupte N, Swaminathan S, Gupta A. PLoS One. 2019;14(7):e0218034. Published 2019 Jul 18. doi:10.1371/journal.pone.0218034. PMID: 31318864; PMCID: PMC6638997.
  9. Mobile phone access and comfort: Implications for HIV and tuberculosis care in India and South Africa
    Cox SN, Elf JL, Lokhande R, Ogale YP, DiAndreth L, Dupuis E, Milovanovic M, Mpongose N, Mave V, Suryavanshi N, Gupta A, Martinson N, Golub JE, Mathad JS. Int J Tuberc Lung Dis. 2019 Jul 1;23(7):865-872. doi: 10.5588/ijtld.18.0542. PMID: 31439120.
  10. Assessment of lung function in successfully treated tuberculosis reveals high burden of ventilatory defects and COPD
    Gupte AN, Paradkar M, Selvaraju S, Thiruvengadam K, Shivakumar SVBY, Sekar K, Marinaik S, Momin A, Gaikwad A, Natrajan P, Prithivi M, Shivaramakrishnan G, Pradhan N, Kohli R, Raskar S, Jain D, Velu R, Karthavarayan B, Lokhande R, Suryavanshi N, Gupte N, Murali L, Salvi S, Checkley W, Golub J, Bollinger R, Mave V, Padmapriyadarsini C, Gupta A. PLoS One. 2019 PLoS One. 2019 May 23;14(5):e0217289. doi: 10.1371/journal.pone.0217289. eCollection 2019. PMID: 31120971; PMCID: PMC6532904.
  11. Sub-therapeutic rifampicin concentration is associated with unfavourable tuberculosis treatment outcomes
    Ramachandran G, Padmapriyadarsini C, Gaikwad S, Kumar AKH, Kannan T, Gupte N, Paradkar M, Danasekaran K, Gomathi NS, Kagal A, Thomas B, Pradhan N, Kadam D, Hanna LE, Balasubramanian U, Kulkarni V, Murali L, Golub J, Gupte A, Shivakumar SVBY, Swaminathan S, Dooley KE, Gupta A, Mave V for the C-TRIUMPh team. Clin Infect Dis. 2019 May 10. pii: ciz380. doi: 10.1093/cid/ciz380. [Epub ahead of print]. PMID: 31075166.
  12. Respiratory health status is associated with treatment outcomes in pulmonary tuberculosis
    Gupte AN, Selvaraju S, Paradkar M, Danasekaran K, Shivakumar SVB, Thiruvengadam K, Dolla C, Shivaramakrishnan G, Pradhan N, Kohli R, John S, Raskar S, Jain D, Momin A, Subramanian B, Gaikwad A, Lokhande R, Suryavanshi N, Gupte N, Salvi S, Murali L, Checkley W, Golub J, Bollinger R, Padmapriyadarsini C, Mave V, Gupta A. International Journal of Tuberculosis and Lung Disease April 2019 1; 23(4): 450-457. Int J Tuberc Lung Dis. 2019 Apr 1;23(4):450-457. doi: 10.5588/ijtld.18.0551. PMID: 31064624.
  13. Diagnosis of TB
    Christopher DJ, Thangakunam B. Recent Advances in Pulmonary Medicine: Proceedings of 21st NAPCON 2019. Lung India. 2019 Nov:46-51.
  14. Interaction of nutritional status and diabetes on active and latent tuberculosis: a cross-sectional analysis
    Kubiak R, Sarkar S, Horsburgh CR Jr, Roy G, Kratz M, Reshma, Knudsen S, Salgame P, Ellner JJ, Drain PK, Hochberg NS. BMC Infect Dis. 2019 Jul 16;19(1):627. doi: 10.1186/s12879-019-4244-4. PMID: 31311495; PMCID: PMC6636094.
  15. Effect of malnutrition on radiographic findings and mycobacterial burden in pulmonary tuberculosis
    Hoyt K, Sarkar S, White LF, Joseph NM, Salgame P, Lakshminarayanan S, Muthaiah M, Kumar SV, Ellner, JJRoy G, Horsburgh CR Jr, Hochberg NS. PLoS ONE. 2019 Mar 27; 14(3). doi: 10.1371/journal.pone.0214011. PMID: 30917170; PMCID: PMC6436704.
  16. Food for thought: The role of undernutrition and diabetes in India’s TB epidemic
    Sinha P, Hochberg NS. International Journal of Medicine and Public Health 2019;9(1):1-3.
  17. Undernutrition and tuberculosis: Public health implications
    Sinha P, Davis J, Saag L, Wanke C, Salgame P, Mesick J, Horsburgh CR Jr, Hochberg NS. J Infect Dis. 2019 Apr 16;219(9):1356-1363. doi: 10.1093/infdis/jiy675. PMID: 30476125; PMCID: PMC6941617.
  18. Crystal ball: The yesterday and tomorrow of tuberculosis
    Sinha P, Hochberg NS. Environ Microbiol Rep. 2019 Feb;11(1):41-44. doi: 10.1111/1758-2229.12726. Epub 2018 Dec 25. PMID: 30585431.
  19. Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy
    Kumar NP, Moideen K, Nancy A, Viswanathan V, Shruthi BS, Sivakumar S, Hissar S, Kornfeld H, Babu S. BMC Infect Dis 2019 Dec 9;19(1):1039. PMID: 31818258; PMCID: PMC6902343.
  20. Plasma chemokines are biomarkers of disease severity, higher bacterial burden and delayed sputum culture conversion in pulmonary tuberculosis
    Kumar NP, Moideen K, Nancy A, Viswanathan V, Shruthi BS, Sivakumar S, Natarajan M, Kornfeld H, Babu S. Sci Rep 2019 Dec 3;9(1):18217. PMID: 31796883; PMCID: PMC6890773.
  21. Plasma eicosanoid levels in tuberculosis and tuberculosis-diabetes co-morbidity are associated with lung pathology and bacterial burden
    Kumar NP, Moideen K, Nancy A, Viswanathan V, Shruthi BS, Shanmugam S, Hissar S, Kornfeld H, Babu S. Front Cell Infect Microbiol 2019 Oct 1;9:335. PMID: 31632923; PMCID: PMC6779700.
  22. Persistent inflammation during anti-tuberculosis treatment with diabetes comorbidity
    Kumar NP, Fukutani KF, Shruthi BS, Alves T, Silveira-Mattos PS, Rocha MS, West K, Natarajan M, Viswanathan V, Babu S, Andrade BB, Kornfeld H. eLife. 2019 Jul 4;8. pii: e46477. PMID: 31271354; PMCID: PMC6660216.
  23. Elevated circulating levels of monocyte activation markers among tuberculosis patients with diabetes co-morbidity
    Kumar NP, Moideen K, Viswanathan V, Sivakumar S, Natarajan M, Kornfeld H, Babu S. Immunology. 2019 Mar;156(3):249-258. PMID: 30427060; PMCID: PMC6376263.
  24. Delamanid central nervous system pharmacokinetics in tuberculous meningitis in rabbits and humans
    Tucker EW, Pieterse L, Zimmerman MD, Udwadia ZF, Peloquin CA, Gler MT, Ganatra S, Tornheim JA, Chawla P, Caoili JC, Ritchie B, Jain SK, Dartois V, Dooley KE. Antimicrob Agents Chemother. 2019 Sep 23;63(10). pii: e00913-19. doi: 10.1128/AAC.00913-19. Print 2019 Oct. PMID: 31383662; PMCID: PMC6761520.
  25. Management of drug-resistant tuberculosis
    Lange C, Dheda K, Chesov D, Mandalakas AM, Udwadia Z, Horsburgh CR Jr. Lancet. 2019 Sep14;394(10202):953-966. doi: 10.1016/S0140-6736(19)31882-3. PMID: 31526739.
  26. A shorter regimen for rifampin-resistant tuberculosis
    Tornheim JA, Udwadia ZF, Gupta A. N Engl J Med. 2019 Sep 12;381(11):e22. doi: 10.1056/NEJMc1905782. PMID: 31509687.
  27. Multi-centre study to establish interpretive criteria for clofazimine drug susceptibility testing
    Ismael N, Said HM, Rodrigues C ,Omar SV, Ajbani K, Sukhadia N, Kohl TA, Niemann S, Kranzer K, Diels M, Rigouts L, Rüsch-Gerdese S, Siddiqi S. Int J Tuberc Lung Dis. 2019 May 1;23(5):594-599. doi: 10.5588/ijtld.18.0417. PMID: 31097068.
  28. Performance of bioMérieux Lowenstein-Jensen slopes in plastic tube packaging, compared to existing phenotypic methods, for efficient recovery of Mycobacterium tuberculosis (MTB) complex
    Nambiar R, Bereksi N, Gonzalez R, Anthony de Cozar, Loubet M, Shetty A, Alex van Belkum, Rodrigues C. J Med Microbiol. 2019 Mar;68(3):398-401. doi: 10.1099/jmm.0.000930. Epub 2019 Feb 6. PMID: 30724723.
  29. Few eligible for the newly recommended short course MDR-TB regimen at a large Mumbai private clinic
    Udwadia ZF, Tornheim JA, Ganatra S, DeLuca A, Rodrigues CS, Gupta A.BMC Infectious Diseases 2019 Jan 28; 19:94, https://doi.org/10.1186/s12879-019-3726-8. PMID: 30691407; PMCID: PMC6350313.
south africa
  1. Zar HJ, Workman LJ, Prins M, Bateman LJ, Mbhele SP, Whitman CB, Denkinger CM, Nicol MP. Tuberculosis Diagnosis in Children Using Xpert Ultra on Different Respiratory Specimens. Am Respir Crit Care Med. 2019 Dec 15;200(12):1531-1538. doi: 10.1164/rccm.201904-0772OC.
  2.  Osei Sekyere J, Reta MA, Maningi NE, Fourie PB. Antibiotic resistance of Mycobacterium tuberculosis complex in Africa: A systematic review of current reports of molecular epidemiology, mechanisms and diagnostics. J Infect. 2019 Dec;79(6):550-571. doi: 10.1016/j.jinf.2019.10.006. Epub 2019 Oct 16.
  3.  Nicol MP, Wood RC, Workman L, Prins M, Whitman C, Ghebrekristos Y, Mbhele S, Olson A, Jones-Engel LE, Zar HJ, Cangelosi GA. Microbiological diagnosis of pulmonary tuberculosis in children by oral swab polymerase chain reaction. Sci Rep. 2019 Jul 25;9(1):10789. doi: 10.1038/s41598-019-47302-5.

archives

BRAZIL 2018
  1. van der Heijden YF, Abdullah F, Andrade BB, Andrews JR, Christopher DJ, Croda J, Ewing H, Haas DW, Hatherill M, Horsburgh CR Jr, Mave V, Nakaya HI, Rolla V, Srinivasan S, Sugiyono RI, Ugarte-Gil C, Hamilton C. Building capacity for advances in tuberculosis research; proceedings of the third RePORT international meeting. Tuberculosis (Edinb). 2018 Dec;113:153-162. doi: 10.1016/j.tube.2018.09.009. Epub 2018 Oct 1. PMID: 30514497; PMCID: PMC6349374.
INDIA 2018
  1. Building capacity for advances in tuberculosis research; proceedings of the third RePORT International meeting
    Van der Heijden YF, Abdullah F, Andrade BB, Andrews JR, Christopher DJ, Croda J, Ewing H, Haas DW, Hatherill M, Horsburgh CR Jr, Mave V, Nakaya HI, Rolla V, Srinivasan S, Sugiyono RI, Ugarte-Gil C, Hamilton C. Tuberculosis (Edinb). 2018;113: 153-162. PMID: 30514497; PMCID: PMC6349374.
  2. Alcohol enhances type 1 interferon-αproduction and mortality of young mice infected with Mycobacterium tuberculosis
    Tripathi D, Welch E, Cheekatla SS, Radhakrishnan R, Venkatasubramanian S, Paidipally P, Van A, Samten B, Devalraju P, Neela V, Valluri V, Mason C, Nelson S and Vankayalapati R. PLoS Pathog. 2018 Aug 2;14(8):e1007174. doi: 10.1371/journal.ppat.1007174. eCollection 2018 Aug. PMID: 30071107; PMCID: PMC6072099.
  3. IL-17 and IL-22 production in HIV+ individuals with latent and active tuberculosis
    Devalraju KP, Neela VSK, Ramaseri SS, Van A, Chaudhury A, Krovvidi SS, Vankayalapati R, Valluri VL. BMC Infect Dis. 2018 Jul 11;18(1):321. doi: 10.1186/s12879-018-3236-0. PMID: 29996789; PMCID: PMC6042451.
  4. Defective MyD88 and IRAK4 but not TLR-2 expression in HIV+ individuals with latent tuberculosis infection
    Devalraju KP, Neela VSK, Gaddam R, Chaudhury A, Van A, Krovvidi SS, Vankaylapati R, Valluri VL. Cytokine. 2018 Oct;110:213-221. doi: 10.1016/j.cyto.2018.05.005. Epub 2018 May 17. PMID: 29778672; PMCID: PMC6103807.
  5. Interleukin-21 regulates Natural Killer cell responses during mycobacterium tuberculosis infection
    Paidipally P, Tripathi D, Van A, Radhakrishnan RK, Dhiman R, Venkatasubramanian S, Devalraju KP, Tvinnereim AR, Valluri VL, Vankayalapati R. J Infect Dis. 2018 Mar 28;217(8):1323-1333. doi: 10.1093/infdis/jiy034. PMID: 29390153; PMCID: PMC6018723.
  6. Association of TNF-α, IL-10 and IL-6 promoter polymorphisms in pulmonary tuberculosis patients and their household contacts of younger age group
    Joshi L, Chelluri LK, Valluri V, Gaddam S. Comp Immunol Microbiol Infect Dis. 2018 Feb;56:20-26. doi: 10.1016/j.cimid.2017.12.001. Epub 2017 Dec 26. PMID: 29406278.
  7. Trends in HbA1c levels and implications for diabetes screening in tuberculosis cases undergoing treatment in India
    Gupte AN, Mave V, Meshram S, Lokhande R, Kadam D, Dharmshale S, Bharadwaj R, Kagal A, Pradhan N, Deshmukh S, Atre S, Sahasrabudhe T, Barthwal M, Meshram S, Kakrani A, Kulkarni V, Raskar S, Suryavanshi S, Shivakoti S, Chon S, Selvin E, Gupte N, Gupta A, Golub JE. Int J Tuberc Lung Dis. 2018 Jul 1;22(7):800-806. doi: 10.5588/ijtld.18.0026. PMID: 30041729; PMCID: PMC6198328.
  8. Diabetes and prediabetes among household contacts of TB patients in India: Is it time to screen them all?
    Shivakumar SVBY, Padmapriyadarsini C, Kumar AMV, Paradkar M, Dhanasekaran K, Suryavanshi N, Thomas B, Kohli R, Thiruvengadam K, Kulkarni V, Hannah LE, Gomathy NS, Pradhan N, Dolla C, Gupte A, Ramachandran G, DeLuca A, Meshram S, Bharadwaj R, Bollinger RC, Golub J, Selvaraj K, Gupte N, Swaminathan S, Mave V, Gupta A for the CTRIUMPH- RePORT India Study Team. Int J Tuberc Lung Dis. 2018 Jun 1; 22(6): 686-694. Doi: 10.5588/ijtld.17.0598. PMID: 29862955.
  9. Sources of household air pollution and their association with fine particulate matter in low-income urban homes in India
    Elf JL, Kinikar A, Khadse S, Mave V, Suryavanshi N, Gupte N, Kulkarni V, Patekar P, Raichur P, Breysse P, Gupta A, Golub JE. J Expo Sci Environ Epidemiol. 2018 Jun;28(4):400-410. Doi: 10.1038/s41370-018-0024-2. Epub 2018 May 23. PMID: 29789668; PMCID: PMC6013356.
  10. Effect of diabetes mellitus on the pharmacokinetics and pharmacodynamics of tuberculosis treatment
    Alfarisi O, Mave V, Gaikwad S, Sahasrabudhe T, Ramachandran G, Kumar H, Gupte N, Kulkarni V, Deshmukh S, Atre S, Raskar S, Lokhande R, Barthwal M, Kakrani A, Chon S, Gupta A, Golub JE, Dooley KE. Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01383-18. doi: 10.1128/AAC.01383-18. Print 2018 Nov. PMID: 30126955; PMCID: PMC6201087.
  11. Barriers to screening and isoniazid preventive treatment for child contacts tuberculosis patients
    Belgaumkar V, Chandanwale A, Valvi C, Pardeshi G, Lokhande R, Kadam D, Joshi S, Gupta N, Jain D, Dhumal G, Deluca A, Golub J, Shankar A, Gupta A, Kinikar A, Bollinger RC. Int J Tuberc Lung Dis. 2018 Oct 1;22(10):1179-1187. doi: 10.5588/ijtld.17.0848. PMID: 30236186.
  12. The association of household fine particulate matter and kerosene with tuberculosis in women and children in Pune, India
    Elf JL, Kinikar A, Khadse S, Mave V, Suryavanshi N, Gupte N, Kulkarni V, Patekar S, Raichur P, Paradkar M, Kulkarni V, Pradhan N, Breysse PN, Gupta A, Golub JE. Occup Environ Med. 2018 Sep 7. pii: oemed-2018-105122. doi: 10.1136/oemed-2018-105122. [Epub ahead of print]. PMID: 30194271.
  13. Tuberculin skin test and QuantiFERON-Gold In tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in a high TB burden setting
    Padmapriyadarsini C, Mave V, Thiruvengadam K, Gupte N, Shivakumar SVBY, Hanna LE, Kulkarni V, Kadam D, Dhanasekaran K, Paradkar M, Thomas B, Kohli R, Dolla C, Bharadwaj R, Sivaramakrishnan GN, Pradhan N, Gupte A, Murali L, Valvi C, Swaminathan S, Gupta A; CTRIUMPH Study Team. PLoS One. 2018 Aug 1;13(8):e0199360. doi: 10.1371/journal.pone.0199360. eCollection 2018. PMID: 30067752; PMCID: PMC6070176.
  14. Addressing knowledge gaps and prevention for tuberculosis-infected Indian adults: A vital part of elimination
    Deluca A, Dhumal G, Paradkar M, Suryavanshi N, Mave V, Kohli R, Shivakumar SVBY, Hulyolkar V, Gaikwad A, Nangude A, Pardeshi G, Kadam D, Gupta A. Published in BMC Infectious Diseases, May 2018. BMC Infect Dis. 2018 May 2;18(1):202. doi: 10.1186/s12879-018-3116-7. PMID: 29720095; PMCID: PMC5932769.
  15. Second hand smoke exposure and validity of self-report in low-income women and children in India
    Elf J, Kinikar A, Khadse S, Mave V, Gupte N, Kulkarni V, Patekar V, Raichur P, Cohen J, Breysse PN, Gupta A, Golub JE. Pediatrics. 2018 Jan; 141 (Suppl 1): S118-S129. doi: 10.1542/peds.2017-1026O. PMID: 29292312; PMCID: PMC5745676.
  16. Thoracoscopic pleural biopsy improves yield of Xpert MTB/RIF for diagnosis of pleural tuberculosis
    Christopher DJ, Dinakaran S, Gupta R, James P, Isaac B, Thangakunam B. Respirology. 2018 Jul;23(7):714-717. Epub 2018 Feb 27. doi: 10.1111/resp.13275. PMID: 29486527.
  17. Low BMI and latent tuberculosis infection: A systematic review and meta-analysis
    Saag LA, LaValley MP, Hochberg NS, Cegielski P, Pleskunas JA, Linas B, Horsburgh CR. Int J Tuberc Lung Dis. 2018 Apr 1;22(4):358-365. doi: 10.5588/ijtld.17.0558. PMID: 29562981.
  18. Existing blood transcriptional classifiers accurately discriminate active tuberculosis from latent infection in individuals from South India
    Leong, S, Yue Zhao, Joseph NM, Hochberg NS, Sarkar S, Pleskunas J, Hom D, Lakshminarayanan S, Horsburgh Jr, CR, Roy G, Ellner JJ, Johnson WE, Salgame, P. Tuberculosis (Edinb). 2018 Mar;109:41-51. doi: 10.1016/j.tube.2018.01.002. Epub 2018 Jan 31. PMID: 29559120.
  19. Elevated levels of matrix metalloproteinases reflect severity and extent of disease in tuberculosis-diabetes co-morbidity and are predominantly reversed following standard anti-tuberculosis or metformin treatment
    Kumar NP, Moideen K, Viswanathan V, Sivakumar S, Menon PA, Kornfeld H, Babu S. BMC Infect Dis. 2018 Jul 25;18(1):345. PMID: 30045688; PMCID: PMC6060542.
  20. Utility of pyrosequencing for rapid detection of tubercular meningitis (TBM) and associated susceptibility directly from CSF specimens
    Ajbani K, Kazi M, Naik S, Soman R, Shetty A, Rodrigues C. Tuberculosis (Edinb). 2018 Jul;111:54-56. doi: 10.1016/j.tube.2018.05.009. Epub 2018 May 19. PMID: 30029915.
  21. Evaluation of pyrosequencing for extensive drug resistance-defining anti-tuberculosis drugs for use in public healthcare
    Nambiar R, Shah D, Ajbani K, Kazi M, Sadani M, Shetty A, Keskar P, Kamble S, van Belkum A, Rodrigues C. Tuberculosis (Edinb). 2018 May;110:86-90. doi: 10.1016/j.tube.2018.03.006. Epub 2018 Mar 26. PMID: 29779779.
  22. Pyrosequencing to resolve discrepant Xpert MTB/RIF and Mycobacterial Growth Indicator Tube 960
    Ajbani K, Kazi M, Tornheim J, Naik S, Soman R, Shetty A, Rodrigues C. Lung India. 2018 Mar-Apr;35(2):168-170. doi: 10.4103/lungindia.lungindia_71_17. PMID: 29487256; PMCID: PMC5846270.
BRAZIL 2017
  1. Miranda P, Gil-Santana L, Oliveira MG, Mesquita ED, Silva E, Rauwerdink A, Cobelens F, Oliveira MM, Andrade BB, Kritski A. Sustained elevated levels of C-reactive protein and ferritin in pulmonary tuberculosis patients remaining culture positive upon treatment initiation. PLoS One. 2017 Apr 6;12(4):e0175278. doi: 10.1371/journal.pone.0175278. PMID: 28384354; PMCID: PMC5383283.
  2. Geadas C, Stoszek SK, Sherman D, Andrade BB, Srinivasan S, Hamilton CD, Ellner J. Advances in basic and translational tuberculosis research: Proceedings of the first meeting of RePORT international. Tuberculosis (Edinb). 2017 Jan;102:55-67. doi: 10.1016/j.tube.2016.11.006. Epub 2016 Nov 27. PMID: 28061953.
BRAZIL 2016
  1. Amaral EP, Conceição EL, Costa DL, Rocha MS, Marinho JM, Cordeiro-Santos M, D’Império-Lima MR, Barbosa T, Sher A, Andrade BB. N-acetyl-cysteine exhibits potent anti-mycobacterial activity in addition to its known anti-oxidative functions. BMC Microbiol. 2016 Oct 28;16(1):251. doi: 10.1186/s12866-016-0872-7. PMID: 27793104; PMCID: PMC5084440.
  2. Mesquita ED, Gil-Santana L, Ramalho D, Tonomura E, Silva EC, Oliveira MM, Andrade BB, Kritski A; Rede-TB Study group. Associations between systemic inflammation, mycobacterial loads in sputum and radiological improvement after treatment initiation in pulmonary TB patients from Brazil: a prospective cohort study. BMC Infect Dis. 2016 Aug 5;16:368. doi: 10.1186/s12879-016-1736-3. PMID: 27494953; PMCID: PMC4974760.
  3. Almeida-Junior JL, Gil-Santana L, Oliveira CA, Castro S, Cafezeiro AS, Daltro C, Netto EM, Kornfeld H, Andrade BB. Glucose Metabolism Disorder Is Associated with Pulmonary Tuberculosis in Individuals with Respiratory Symptoms from Brazil. PLoS One. 2016 Apr 14;11(4):e0153590. doi: 10.1371/journal.pone.0153590. PMID: 27078026; PMCID: PMC4831681.
  4. Gil-Santana L, Almeida-Junior JL, Oliveira CA, Hickson LS, Daltro C, Castro S, Kornfeld H, Netto EM, Andrade BB. Diabetes Is Associated with Worse Clinical Presentation in Tuberculosis Patients from Brazil: A Retrospective Cohort Study. PLoS One. 2016 Jan 11;11(1):e0146876. doi: 10.1371/journal.pone.0146876. PMID: 26752596; PMCID: PMC4709051.
BRAZIL 2015
  1. Hamilton CD, Swaminathan S, Christopher DJ, Ellner J, Gupta A, Sterling TR, Rolla V, Srinivasan S, Karyana M, Siddiqui S, Stoszek SK, Kim P. RePORT International: Advancing Tuberculosis Biomarker Research Through Global Collaboration. Clin Infect Dis. 2015 Oct 15;61Suppl 3(Suppl 3):S155-9. doi: 10.1093/cid/civ611. PMID: 26409277; PMCID: PMC4583572.
Philippines 2015, 2016
  1. Lopez AL, Aldaba JG, Ama CG, Sylim PG, Geraldino XD, Sarol JN, Salonga AM. Surveillance for tuberculosis in a rural community in The Philippines. Int J Tuberc Lung Dis 2016; 20(11):1495–1500. http://dx.doi.org/10.5588/ijtld.16.0027

     

  2. Alejandria, MM, Roa K, Serrano GK, Itable JR, Castillo-Carandang NT, Baja ES. Enhancing and maximizing participation of private health facilities in TB control. Policy Notes – Philippine Institute of Development Studies 2015; 29: 1-10

     

  3. Baja ES, Alejandria MM, Castillo-Carandang N, Itable JR, Serrano GK, Lansang MAD. Tuberculosis and diabetes mellitus control and care: The need for a coordinated response. Policy Notes – Philippine Institute of Development Studies 2015; 19: 1-8.

INDIA 2017
  1. IL-21-dependent expansion of memory-like NK cells enhances protective immune responses against Mycobacterium tuberculosis
    Venkatasubramanian S, Cheekatla S, Paidipally P, Tripathi D, Welch E, Tvinnereim AR, Nurieva R, Vankayalapati R. Mucosal Immunol. 2017 Jul;10(4):1031-1042. doi: 10.1038/mi.2016.105. Epub 2016 Dec 7. PMID: 27924822; PMCID: PMC5462891.
  2. IL-6 and IL-18 cytokine gene variants of pulmonary tuberculosis patients with co-morbid diabetes mellitus and their household contacts in Hyderabad
    Ponnana M, Sivangala R, Joshi L, Valluri V, Gaddam S. Gene. 2017 Sep 5;627:298-306. doi: 10.1016/j.gene.2017.06.046. Epub 2017 Jun 23. PMID: 28652186.
  3. Isoniazid concentrations in hair and plasma area-under-the-curve exposure among children with tuberculosis
    Mave V, Kinikar A, Kagal A, Nimkar S, Koli H, Khwaja S, Bharadwaj R, Gerona R, Wen A, Ramachandran G, Kumar H, Bacchetti P, Dooley KE, Gupte N, Gupta A, Gandhi M. PLoS One. 2017 Dec 7;12(12):e0189101. doi: 10.1371/journal.pone.0189101. PMID: 29216273; PMCID: PMC5720757.
  4. Prevalence of dysglycemia and clinical presentation of pulmonary tuberculosis in Western India
    Mave V, Meshram S, Lokhande R, Kadam D, Dharmshale S, Bharadwaj R, Kagal A, Pradhan N, Deshmukh S, Atre S, Sahasrabudhe T, Barhwal M, Meshram S, Kakrani A, Kulkarni V, Raskar S, Suryavanshi N, Shivakoti R, Chon S, Selvin E, Gupte A, Gupta A, Gupte N, Golub J. Int J Tuberc Lung Dis. 2017 Dec 1;21(12):1280-1287. doi: 10.5588/ijtld.17.0474. PMID: 29297449; PMCID: PMC6203962.
  5. Comorbidities in pulmonary tuberculosis cases in Puducherry and Tamil Nadu, India: Opportunities for intervention
    Hochberg NS, Sarkar S, Horsburgh, Jr, CR, Knudsen S, Pleskunas J, Sahu S, Kubiak RW, Govindarajan S, Salgame P, Lakshminarayanan S, Sivaprakasam A, White LF, Joseph NM, Ellner JJ, Roy G. PLoS One. 2017 Aug 23;12(8):e0183195. doi: 10.1371/journal.pone.0183195. eCollection 2017. PMID: 28832615; PMCID: PMC5568341.
  6. Predictors of delayed care seeking for tuberculosis in Southern India: An observational study
    Van Ness SE, Chandra A, Sarkar S, Pleskunas J, Ellner JJ, Roy G, Lakshminarayanan S, Sahu S, Horsburgh Jr CR, Jenkins HE, Hochberg NS. BMC Infect Dis. 2017 Aug 15;17(1):567. doi: 10.1186/s12879-017-2629-9. PMID: 28806911; PMCID: PMC5557420.
  7. Systems immunology of diabetes tuberculosis comorbidity reveals signatures of disease complications
    Prada-Medina CA, Fukutani KF, Kumar NP, GilSantana L, Babu S, Lichtenstein F, West K, Sivakumar S, Menon PA, Viswanathan V, Andrade BB, Nakaya H, Kornfeld H. Sci Rep. 2017 May 17;7(1):1999. PMID: 28515464; PMCID: PMC5435727.
  8. Defining a research agenda to address the converging epidemics of tuberculosis and diabetes. Part 2: Underlying biological mechanisms
    Ronacher K, van Crevel R, Critchley J, Bremer A, Schlesinger LS, Kapur A, Basaraba R, Kornfeld H, Restrepo BI. Chest. 2017 Jul;152(1):174-180. PMID: 28434937; PMCID: PMC5577357.
  9. Defining a research agenda to address the converging epidemics of tuberculosis and diabetes. Part 1: Epidemiology and clinical management
    Critchley JA, Restrepo BI, Ronacher K, Kapur A, Bremer AA, Schlesinger LS, Basaraba R, Kornfeld H, van Crevel R. Chest. 2017 Jul;152(1):165-173. PMID: 28434936; PMCID: PMC5989639.
  10. Tuberculosis-diabetes co-morbidity is characterized by heightened systemic levels of circulating angiogenic factors
    Kumar NP, Moideen K, Sivakumar S, Menon PA, Viswanathan V, Kornfeld H, Babu S. J Infect. 2017 Jan;74(1):10-21. PMID: 27717783; PMCID: PMC5164955.
  11. Heightened circulating levels of antimicrobial peptides in tuberculosis-diabetes co-morbidity and reversal upon treatment
    Kumar NP, Moideen K, Viswanathan V, Sivakumar S, Menon PA, Kornfeld H, Babu S. PLoS One. 2017 Sep 14;12(9):e0184753. doi: 10.1371/journal.pone.0184753. eCollection 2017. PMID: 28910369; PMCID: PMC5599016.
INDIA 2016
  1. NK-CD11c+ cell crosstalk in diabetes enhances IL-6-mediated inflammation during Mycobacterium tuberculosis infection
    Cheekatla SS, Tripathi D, Venkatasubramanian S, Nathella PK, Paidipally P, Ishibashi M, Welch E, Tvinnereim AR, Ikebe M, Valluri VL, Babu S, Kornfeld H, Vankayalapati R. PLoS Pathog. 2016 Oct 26;12(10):e1005972. doi: 10.1371/journal.ppat.1005972. eCollection 2016. PMID: 27783671; PMCID: PMC5082658.
  2. Polymorphisms of IFN-γ (+874A/T) and IL-12 (+1188A/C) in tuberculosis patients and their household contacts in Hyderabad, India
    Thada S, Ponnana M, Sivangala R, Joshi L, Alasandagutti M, Ansari MS, Schumann RR, Valluri V, Gaddam S. Hum Immunol. 2016 Jul;77(7):559-65. doi: 10.1016/j.humimm.2016.04.016. Epub 2016 Apr 22. PMID: 27108964.
  3. Cytokine production and mRNA expression in pulmonary tuberculosis patients and their household contacts of younger age group
    Joshi L, Ponnana M, Sivangala R, Chelluri LK, Nallari P, Valluri VL, Gaddam S. J Immunol Methods. 2016 May;432:65-71. doi: 10.1016/j.jim.2016.02.012. Epub 2016 Feb 12. PMID: 26876300.
  4. Isoniazid hair concentrations in children with tuberculosis: A proof of concept study
    Mave V, Chandanwale A, Kinikar A, Khadse S, Kagal A, Gupte N, Suryavanshi N, Nimkar S, Koli H, Khwaja S, Bharadwaj R, Joshi S, Horng H, Benet LZ, Ramachandran G, Dooley KE, Gupta A, Gandhi M. Int J Tuberc Lung Dis. 2016 Jun; 20(6): 844–847. doi: 10.5588/ijtld.15.0882. PMID: 27155191; PMCID: PMC4889729.
  5. Cohort for Tuberculosis Research by the Indo-U.S. Medical Partnership (CTRIUMPH): Protocol for a multicentric prospective observational study
    Gupte A, Padmapriyadarsini C, Mave V, Kadam D, Suryavanshi N, Shivakumar SVBY, Kohli R, Gupte N, Thiruvengadam K, Kagal A, Meshram S, Bharadwaj R, Khadse S, Ramachandran G, Hanna LE, Pradhan N, Gomathy NS, DeLuca A, Gupta A, Swaminathan S; CTRIUMPH Study Team. BMJ Open 2016 Feb 25;6(2):e010542. PMID: 26916698; PMCID: PMC4769396.
  6. Modulation of dendritic cell and monocyte subsets in tuberculosis-diabetes co-morbidity upon standard tuberculosis treatment
    Kumar NP, Moideen K, Sivakumar S, Menon PA, Viswanathan V, Kornfeld H, Babu S. Tuberculosis (Edinb). 2016 Dec; 101:191-200. PMID: 27865391; PMCID: PMC5127284.
  7. Effect of standard tuberculosis treatment on naive, memory and regulatory T-cell homeostasis in tuberculosis-diabetes co-morbidity
    Kumar NP, Moideen K, Viswanathan V, Kornfeld H, Babu S. Immunology. 2016 Sep;149(1):87-97. PMID: 27289086; PMCID: PMC4981606.
  8. Glucose metabolism disorder is associated with pulmonary tuberculosis in individuals with respiratory symptoms from Brazil
    Almeida-Junior JL, Gil-Santana L, Oliveira CA, Castro S, Cafezeiro AS, Daltro C, Netto EM, Kornfeld H, Andrade BB. PLoS One. 2016 Apr 14;11(4):e0153590. PMID: 27078026; PMCID: PMC4831681.
  9. High prevalence and heterogeneity of diabetes in patients with TB in South India: A report from the Effects of Diabetes on Tuberculosis Severity (EDOTS) Study
    Kornfeld H, West K, Kane K, Kumpatla S, Zacharias RR, Martinez-Balzano C, Li W, Viswanathan V. Chest. 2016 Jun;149(6):1501-8. PMID: 26973015; PMCID: PMC4944775.
INDIA 2015
  1. RePORT International: Advancing tuberculosis biomarker research through global collaboration
    Hamilton CD, Swaminathan S, Christopher DJ, Ellner J, Gupta A, Sterling TR, Rolla V, Srinivasan S, Karyana M, Siddiqui S, Stoszek SK, Kim P. Clinical Infectious Diseases (CID). 2015 October 15; 61(Suppl 3): S155–S159. PMID: 26409277; PMCID: PMC4583572.